desc,gpt4
ulcerative colitis,1.0
ulcerative colitis (chronic),1.0
ulceration of intestine,0.75
intestinal e.coli,0.1
escherichia coli,0.1
regional enteritis,0.0
irritable bowel syndrome,0.1
diarrhea,0.5
duodenal ulcer,0.0
enema set,0.65
intestinal infection,0.1
enterobacteriaceae,0.1
constipation,0.1
e. coli,0.0
anal and rectal conditions,0.5
bacterial enteritis,0.1
colon cancer,0.2
diverticulosis,0.1
colorectal resection,0.75
colonoscopy and biopsy,0.75
intestinal helminthiases,0.0
mesalamine,0.95
oligosaccharides,0.1
dinutuximab,0.0
other intestinal obstruction,0.25
diverticulitis,0.1
colorectal cancer,0.25
toxic gastroenteritis and colitis,0.5
viral enteritis,0.0
duoderm,0.1
unna flex,0.0
congenital anomalies of intestine,0.1
mucin clot,0.1
indomethacin,0.1
decubitus ulcer,0.0
epithelial cells,0.1
enterovirus identified,0.1
inspirease,0.0
flex-all,0.0
eosinophilic esophagitis,0.1
dextran,0.1
relugolix,0.0
fecal immunochemical test,0.25
alkaline phosphatase.intestinal/alkaline phosphatase.total,0.25
mucus,0.1
ulcer of esophagus,0.1
eosinophils,0.25
reflux esophagitis,0.0
other bowel diagnostic procedures,0.5
ej ab,0.0
eosinophil count,0.25
eosinophils - urine,0.05
transitional epithelia,0.05
ige,0.1
alvimopan,0.1
functional digestive disorders,0.1
absolute eosinophils,0.25
eosinophilia,0.1
renament,0.0
unit division,0.0
helminthiases,0.1
eosinophil,0.2
ictotest,0.0
inflammatory bowel disease ab panel,0.75
amerigel,0.1
entacapone,0.0
exploratory laparotomy,0.25
color,0.0
urinary incontinence,0.1
epithelial casts,0.05
ileostomy status,0.5
transitional cells,0.05
events counted,0.0
pouch,0.75
digestive congenital anomalies,0.1
eosinophils count,0.25
irrigator,0.1
ethynodiol,0.05
duodenitis,0.1
probiotic,0.65
amcinonide,0.05
alprostadil,0.05
specimen,0.0
product code,0.0
exenatide,0.0
specimen container,0.1
indwelling catheter,0.05
irinotecan,0.05
units ordered,0.0
gastric ulcer,0.0
umeclidinium,0.0
urinary amorphous sediments,0.0
aldolase,0.1
ascvd,0.0
cystitis,0.0
gastrointestinal complications,0.5
urinary obstruction,0.1
eucerin,0.0
inflammatory bowel disease and other gastroenteritis and colitis,0.75
vascular insufficiency of intestine,0.1
stomatitis and mucositis (ulcerative),0.1
chronic vascular insufficiency of intestine,0.1
acute vascular insufficiency of intestine,0.1
intestinal infection due to c. difficile,0.2
"peptic ulcer, site unspecified",0.0
angiodysplasia of intestine (without mention of hemorrhage),0.1
intestinal malabsorption (non-celiac),0.1
chronic ulcer of unspecified site,0.5
hemorrhage from gastrointestinal ulcer,0.4
stomatitis and mucositis,0.1
unstable angina (intermediate coronary syndrome),0.0
celiac disease,0.1
ulceration of the lower gi tract,0.75
polyarteritis nodosa,0.1
acute gastritis,0.0
acute pancreatitis,0.1
behcet's syndrome,0.1
urethral stricture (not specified as infectious),0.0
arteritis nos,0.1
atherosclerosis of native arteries of the extremities with intermittent claudication,0.0
peptic ulcer (excl. esophageal),0.0
sicca syndrome,0.1
impaction of intestine,0.2
benign neoplasm of colon,0.0
noninfectious gastroenteritis,0.5
acute cystitis,0.0
urticaria,0.1
giant cell arteritis,0.05
hemorrhoids,0.1
corneal ulcer,0.0
ischemic heart disease,0.0
chronic ulcer of skin,0.1
inflammatory and toxic neuropathy,0.1
"inflammatory disease of cervix, vagina, and vulva",0.0
gerd,0.1
acute appendicitis,0.05
heartburn,0.1
"gastritis and duodenitis, nos",0.1
paralytic ileus,0.2
abdominal pain,0.4
appendicitis,0.0
other disorders of intestine,0.5
takayasu's disease,0.1
phosphatase alkaline intestine,0.1
renal colic,0.0
stricture of artery,0.0
upper gastrointestinal congenital anomalies,0.0
uri kleen,0.0
periodontitis (acute or chronic),0.1
"acute, but ill-defined cerebrovascular disease",0.0
carditis,0.1
stricture and stenosis of esophagus,0.05
gastritis and duodenitis,0.1
inflammatory conditions of jaw,0.05
acute (transverse) myelitis,0.1
"inflammatory diseases of uterus, except cervix",0.0
acute inflammatory pelvic disease,0.1
barrett's esophagus,0.1
cystitis and urethritis,0.0
anorexia,0.1
ulipristal,0.0
hepatitis c,0.1
gingivitis,0.1
"uveitis, noninfectious or nos",0.25
angina pectoris,0.0
unspecified diffuse connective tissue disease,0.0
nonspecific abnormal findings in stool contents,0.25
necroinflammatory activity grade,0.5
"acute glomerulonephritis, nos",0.05
polymyalgia rheumatica,0.1
"pelvic inflammatory disease, nos",0.0
"esophagitis, gerd and related diseases",0.0
calprotectin,0.85
mercaptopurine,0.75
thiopurine methyltransferase,0.75
proctoscopy and anorectal biopsy,0.75
infliximab,0.9
vedolizumab,0.95
infliximab (group:inflixmab),0.9
interpretation (infliximab) (group:inflmb-int),0.9
infliximab ab,0.9
adalimumab (group:adalmmb),0.9
6-thioguanine,0.75
balsalazide,0.95
tpmt gene targeted mutation analysis,0.75
adalimumab,0.9
hemorrhage of rectum and anus,0.5
c reactive protein,0.5
other or lower gi therapeutic procedures,0.75
crp (mg/l) (group:crpt),0.5
blood in stool,0.75
personal history of diseases of digestive system,0.5
symptoms involving digestive system,0.25
azathioprine,0.75
golimumab,0.9
budesonide,0.75
lactoferrin,0.65
sulfasalazine,0.9
pyoderma,0.1
mycobacterium tuberculosis stimulated gamma interferon esat-6 ag spot count,0.1
colestipol,0.1
erythrocyte sedimentation rate,0.25
hyoscyamine,0.75
metronidazole,0.65
certolizumab pegol,0.9
dicyclomine,0.25
clostridioides difficile toxin genes,0.25
gastrointestinal hemorrhage,0.5
interpretation (cdiff) (group:cdiff-int),0.2
clostridioides difficile toxin a+b,0.25
opium,0.25
cholestyramine resin,0.25
methscopolamine,0.2
clostridioides difficile glutamate dehydrogenase,0.25
mycobacterium tuberculosis tuberculin stimulated gamma interferon,0.1
ustekinumab,0.9
ferumoxytol,0.2
anal and rectal polyp,0.4
magnesium sulfate / potassium sulfate / sodium sulfate,0.1
mycobacterium tuberculosis stimulated gamma interferon release by cd4+ t-cells,0.1
mitogen stimulated gamma interferon,0.25
hydrocortisone,0.75
lower gastrointestinal x-ray,0.5
mycobacterium bovis tuberculin stimulated gamma interferon-control stimulated gamma interferon,0.0
atropine / diphenoxylate,0.25
giardia sp ag,0.0
immunologist review,0.25
"upper gastrointestinal endoscopy, biopsy",0.1
lactobacillus-containing product,0.25
iron deficiency anemia secondary to blood loss (chronic),0.65
complication of colostomy or enterostomy,0.5
cholangitis,0.25
interpretation (intestinal biopsy) (group:intbiop),0.75
palatinase,0.0
"lactase, tissue (group:lactase-tiss)",0.1
"maltase, tissue (group:maltase-tiss)",0.0
sucrase,0.1
disaccharidase panel (group:dispnl),0.1
beta galactosidase,0.1
atrophic gastritis,0.0
loperamide,0.65
iron deficiency anemias,0.5
prednisone,0.75
diverticulosis and diverticulitis,0.0
"pouch,ostomy",0.65
clostridioides difficile,0.25
giardia lamblia ag,0.1
"paste,stomahesive",0.65
ankylosing spondylitis,0.25
other inflammatory spondylopathies,0.3
"belt,ostomy",0.75
peritonitis and retroperitoneal infections,0.2
intestinal obstruction without mention of hernia,0.25
electrolytes/peg-3350,0.25
"lubricant,deodorant",0.1
adapt,0.0
"barrier,ostomy",0.5
ova and parasites identified,0.1
oral wafer,0.5
stomahesive wafer,0.75
abnormal findings on exam of gastrointestinal tract/ abdominal area,0.25
"clamp,bag",0.1
stomahesive powder,0.65
durahesive wafer,0.75
adhesive remover,0.05
olsalazine,0.95
vancomycin,0.25
"colostomy, temporary and permanent",0.65
gastrojejunal ulcer,0.0
other non-or lower gi therapeutic procedures,0.65
screening for malignant neoplasms,0.25
ct scan abdomen,0.5
primary biliary cirrhosis,0.1
hemorrhage of gastrointestinal tract,0.5
belt,0.0
"disorders secondary to childbirth, surgery, trauma",0.05
convex insert,0.1
small bowel resection,0.25
benign neoplasm of other parts of digestive system,0.0
"malignant neoplasm of rectum, rectosigmoid junction, and anus",0.2
fidaxomicin,0.1
flatulence,0.25
thiopurine methyltransferase result,0.75
6-methylmercaptopurine,0.75
legionella pneumophila (serogroup 1),0.0
rotavirus ag,0.1
leukocytes,0.2
"legionella pneumophila (serogroup 2-6, 8)",0.0
chlamydia trachomatis iga,0.05
chlamydophila psittaci iga,0.0
chlamydia trachomatis igg,0.05
chlamydia trachomatis igm,0.05
chlamydophila psittaci igm,0.0
chlamydophila psittaci igg,0.0
micro flexitest result,0.05
constitutional aplastic anemia,0.0
chlamydophila pneumoniae igg,0.05
chlamydophila pneumoniae igm,0.0
chlamydophila pneumoniae iga,0.05
arthropod-borne diseases,0.0
bartonella quintana dna,0.05
bartonella henselae dna,0.05
loperamide / simethicone,0.25
"fluorescence in situ hybridization, high-grade lymphoma",0.1
fecal white blood cell count,0.65
lacticaseibacillus rhamnosus gg,0.65
stool white blood cells,0.65
027-north american pulsed field type 1-binary toxin positive strain,0.0
"norovirus ribonucleic acid, reverse transcription-polymerase chain reaction",0.1
cytomegalovirus,0.25
molecular class one typing,0.1
galileo extended dual polarity antibody identification panel,0.0
hemoglobinuria,0.05
baker's yeast (saccharomyces cerevisiae) iga,0.4
baker's yeast (saccharomyces cerevisiae) igg,0.4
cryptosporidium parvum identified,0.1
malignant cells,0.1
nonspecific abnormal results of other endocrine function study,0.05
hbb gene targeted mutation analysis,0.0
escherichia coli shiga-like toxin,0.1
lactase,0.1
vonicog alfa,0.0
ova and parasite source,0.1
white blood cell count smear,0.1
source white blood cell count,0.25
psyllium,0.65
urine chloride,0.05
two additional markers reflex,0.1
gastrointestinal malfunction arising from mental factors,0.1
bifidobacterium animalis,0.25
free hemoglobin,0.1
cyclospora cayetanensis,0.1
leukemia/lymphoma tissue,0.05
t lymphocyte markers,0.25
buffy coat for wright stain,0.1
polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride,0.25
multiple expressions,0.95
penciclovir,0.0
cd117 ag,0.0
cells.cd13/100 cells,0.0
myeloid markers,0.1
cells.cd38/100 cells,0.1
cells.cd33/100 cells,0.0
cells.cd45/100 cells,0.1
cells.cd10/100 cells,0.0
cells.cd11c/100 cells,0.1
cells.cd23/100 cells,0.05
diseases of lips,0.05
psoriasis vulgaris,0.0
cancer chemotherapy,0.1
tramadol,0.1
iron,0.25
mineral deficiency nec,0.1
acquired absence of breast,0.0
neomycin,0.25
cobalamin,0.25
osteoarthritis; localized,0.0
cefoxitin,0.1
psoriasis,0.1
elevated c-reactive protein (crp),0.4
other biliary tract disease,0.1
psoriasis and related disorders,0.1
glucagon,0.05
polyethylene glycol 3350 with electrolytes,0.25
lidocaine / tetracaine topical product,0.05
hepatitis b virus surface ag,0.1
varicella zoster virus igg,0.1
triacylglycerol lipase,0.05
osteoarthrosis,0.1
hematology studies,0.1
epstein barr virus capsid igg,0.1
nonspecific findings on examination of blood,0.1
disorders involving the immune mechanism,0.25
vitamin d deficiency,0.25
immunity deficiency,0.1
amylase,0.05
abnormal serum enzyme levels,0.2
other symptoms involving abdomen and pelvis,0.2
"diseases of the oral soft tissues, excluding lesions specific for gingiva and tongue",0.05
allergy/adverse effect of penicillin,0.0
chemotherapy,0.2
gamma glutamyl transferase,0.1
vitamin deficiency,0.2
"influenza virus vaccine, inactivated",0.0
basophils/100 leukocytes,0.1
eosinophils/100 leukocytes,0.1
lymphocytes,0.1
segmented neutrophils,0.2
lymphocytes/100 leukocytes,0.1
monocytes/100 leukocytes,0.1
neutrophils,0.25
neutrophils.band form/100 leukocytes,0.1
neutrophils.segmented/100 leukocytes,0.1
elevated white blood cell count,0.25
abnormality of red blood cells,0.2
hypovolemia,0.2
bipolar,0.0
poisoning by antibiotics,0.05
methylprednisolone,0.75
zinc,0.1
cortisol,0.1
"rheumatism, unspecified and fibrositis",0.1
cortisol free,0.1
adrenogenital disorders,0.0
glucocorticoid deficiency,0.1
cortisone,0.75
dexamethasone,0.65
asthma with exacerbation,0.0
hemorrhoid procedures,0.2
other specified gastritis,0.1
demeclocycline,0.0
pramoxine,0.25
collagen crosslinked n-telopeptide,0.05
scopolamine,0.1
bismuth subgallate,0.1
salmonella typhi ty21a live antigen,0.0
disorders of adrenal glands,0.05
tetracycline,0.1
clarithromycin,0.1
nornicotine,0.0
intestinal infection due to protozoa,0.1
norcotinine,0.0
rheumatoid arthritis,0.1
appendiceal conditions,0.1
fiber,0.0
sarcoidosis,0.1
candidiasis,0.1
nausea and vomiting,0.2
levofloxacin,0.1
prurigo and lichen,0.1
collagen crosslinked c-telopeptide,0.05
nitazoxanide,0.1
adrenal cortical steroids causing adverse effects in therapeutic use,0.25
ceftriaxone,0.1
allergic purpura,0.0
TPMT gene targeted mutation analysis,0.2
mycobacterium tuberculosis stimulated gamma interferon,0.05
iron binding capacity,0.1
deodorant,0.0
lactic acid bacteria,0.1
karaya gum,0.05
total 25-hydroxy vitamin d concentration,0.05
c-reactive protein,0.2
tofacitinib,0.85
ileostomy and other enterostomy,0.75
other serum reaction due to administration of blood and blood products,0.0
thiopurine metabolite 6mp,0.75
tmpt genotype,0.05
primary sclerosing cholangitis,0.75
mixing study,0.05
"legionella ab panel, ifa focus",0.05
drug unknown,0.1
Rotavirus Ag,0.05
pump/other vendor,0.0
vonwillebrandfactorrecomb1intlunit,0.0
=vonwillebrand/ahffactor,0.0
chlamydophila pneumoniae ab,0.05
stool parasite screen,0.2
gown - sterile,0.0
vibrio culture(stool),0.2
cryptosporidium sp,0.1
mesna,0.1
acquired absence of intestine (large) (small),0.2
humate-p(ahf/vonwillfctrcmplx)1intlunit,0.0
alum_1%_irrigation_1000_ml,0.05
long term (current) use of selective estrogen receptor modulators (serms),0.1
benzocaine topical,0.1
molecular class i hla typing,0.1
"cytomegalovirus culture, rapid",0.1
miconazole topical,0.05
specimen type,0.0
hydrocerin cream,0.05
miscellaneous micro,0.1
pump connect,0.0
ova and parasites w giardia profile,0.1
"fall from other furniture, subsequent encounter",0.0
pump disconnect,0.05
galileo extenddp antibody id panel,0.1
family history of malignant neoplasm of digestive organs,0.2
accidents occurring in industrial places and premises,0.0
attention to unspecified artificial opening,0.2
consult / referral to surgical oncology,0.2
hydrocortisone / pramoxine,0.25
dalteparin,0.05
iron polysaccharide,0.2
phlebitis and thrombophlebitis,0.05
ferric carboxymaltose,0.25
elevated sedimentation rate,0.25
bifidobacterium/lactobacillus,0.1
calcium citrate,0.05
vascular complications of surgery and medical procedures,0.05
abnormal results of function study of liver,0.2
lidocaine-sodium bicarbonate,0.1
smooth muscle ab,0.05
Smooth Muscle IgG,0.1
other anemias,0.3
Pathology study,0.65
phenol topical product,0.1
cancer ag 19-9,0.05
phlebitis and thrombophlebitis of intracranial venous sinuses,0.0
bacitracin / polymyxin b ophthalmic product,0.0
Liver kidney microsomal Ab,0.1
vitamin d+metabolites,0.1
actin smooth muscle igg,0.1
varicella zoster virus ab,0.05
epstein barr virus nuclear igg,0.05
epstein barr virus nuclear ab,0.05
hepatitis b virus surface ab,0.05
pentafluoropropane-tetrafluoroethane topical,0.05
epstein barr virus early diffuse igg,0.05
epstein barr virus early igg,0.05
epstein barr virus early ab,0.05
folate,0.1
epstein barr virus capsid igm,0.05
ferritin,0.1
iron sucrose,0.25
other arthropathies,0.1
hepatitis nos,0.05
timolol ophthalmic product,0.0
deep vein thrombosis [dvt],0.1
transferrin,0.1
beta globulin,0.1
other disorders of testis,0.0
acquired absence of organs,0.05
globulin,0.05
other disorders of biliary tract,0.05
liver replaced by transplant,0.05
"symptoms concerning nutrition, metabolism, and development",0.25
esophageal bleeding (varices/hemorrhage),0.1
other disorders of stomach and duodenum,0.2
diaphragmatic hernia,0.0
liver abscess and sequelae of chronic liver disease,0.05
cardiomegaly,0.05
"poisoning by analgesics, antipyretics, and antirheumatics",0.05
other immunological findings,0.2
myocardial infarction,0.0
nonspecific chest pain,0.05
protein-calorie malnutrition,0.45
ventral hernia,0.05
neoplasm of unspecified nature of digestive system,0.1
other and unspecified coagulation defects,0.05
other disorders of the kidney and ureters,0.05
bacteremia,0.2
chronic pain syndrome,0.2
pneumonia,0.0
"overweight, obesity and other hyperalimentation",0.1
poisoning/allergy of sulfonamides,0.05
staphylococcus infections,0.05
alcoholism,0.0
acid-base balance disorder,0.1
osteoporosis,0.05
altered mental status,0.1
lower gastrointestinal congenital anomalies,0.1
allergic reaction to food,0.05
abnormal weight gain,0.1
dizziness and giddiness (light-headedness and vertigo),0.1
cancer of stomach,0.05
other infectious and parasitic diseases,0.1
heart failure with preserved ef [diastolic heart failure],0.0
retention of urine,0.1
abnormal glucose,0.1
substance addiction and disorders,0.05
bacterial pneumonia,0.0
hypotension nos,0.1
nephritis and nephropathy without mention of glomerulonephritis,0.05
diseases of pancreas,0.05
other symptoms,0.1
cyst and pseudocyst of pancreas,0.05
splenomegaly,0.2
heart failure with reduced ef [systolic or combined heart failure],0.0
respiratory failure,0.05
myalgia and myositis unspecified,0.05
depression,0.1
dysphagia,0.1
chronic airway obstruction,0.0
"paroxysmal tachycardia, unspecified",0.0
primary/intrinsic cardiomyopathies,0.0
abnormal electrocardiogram [ecg] [ekg],0.0
adjustment reaction,0.1
other abnormal blood chemistry,0.2
disorders of plasma protein metabolism,0.1
asacol,0.9
aicd generator procedures,0.0
"tissue transglutaminase ab, iga",0.1
disorders of the biliary tract with cc,0.05
"acute myocardial infarction, expired with cc",0.0
major small and large bowel procedures with cc,0.65
sedimentation rate,0.2
2 ml ondansetron 2 mg/ml injection,0.1
ciprofloxacin 500 mg oral tablet,0.2
dexamethasone 1.5 mg oral tablet,0.25
"heparin sodium, porcine 5000 unt/ml injectable solution",0.05
metamucil,0.1
100 ml metronidazole 5 mg/ml injection,0.25
metronidazole 500 mg oral tablet,0.25
pentasa,0.9
glucose,0.05
other digestive system diagnoses with cc,0.25
rdw,0.05
mch,0.0
red blood cells,0.1
mcv,0.05
mchc,0.05
white blood cells,0.1
hemoglobin,0.1
loperamide hydrochloride 2 mg oral capsule,0.25
"cardiac defibrillator implant with cardiac catheterization with ami, hf or shock without mcc",0.0
calcium chloride 0.0014 meq/ml / potassium chloride 0.004 meq/ml / sodium chloride 0.103 meq/ml / sodium lactate 0.028 meq/ml injectable solution,0.05
hematocrit,0.1
creatinine,0.1
calcium carbonate 500 mg chewable tablet,0.05
estimated gfr (mdrd equation),0.1
platelet count,0.1
"iron binding capacity, total",0.1
blue top hold,0.0
urea nitrogen,0.1
amoxicillin 875 mg / clavulanate 125 mg oral tablet,0.05
light green top hold,0.0
protonix,0.1
1000 ml glucose 50 mg/ml / potassium chloride 0.02 meq/ml / sodium chloride 4.5 mg/ml injection,0.05
oxycodone hydrochloride 5 mg oral tablet,0.1
vitamin b12,0.2
dicyclomine hydrochloride 10 mg oral capsule,0.25
midazolam 1 mg/ml injectable solution,0.0
"esophagitis, gastroenteritis and miscellaneous digestive disorders without mcc",0.2
ph,0.0
lipase,0.05
hepatitis a virus antibody,0.05
urine volume,0.05
1000 ml glucose 50 mg/ml / sodium chloride 4.5 mg/ml injection,0.05
acetaminophen 325 mg oral tablet,0.05
24 hr creatinine,0.1
asparate aminotransferase (ast),0.1
alanine aminotransferase (alt),0.1
percutaneous cardiovascular procedures with non-drug-eluting stent with mcc or 4+ arteries or stents,0.0
25-oh vitamin d,0.1
delta d3,0.0
500 ml sodium chloride 9 mg/ml injection,0.05
uhold,0.0
magnesium,0.1
percutaneous cardiovascular procedures with non-drug-eluting stent without mcc,0.0
bilirubin,0.1
ketone,0.1
protein,0.05
blood,0.1
urobilinogen,0.05
specific gravity,0.05
nitrite,0.1
urine appearance,0.05
urine mucous,0.05
200 ml ciprofloxacin 2 mg/ml injection,0.1
alkaline phosphatase,0.1
acute pain,0.25
green top hold (plasma),0.0
anti-nuclear antibody,0.1
length of urine collection,0.05
phosphate,0.05
albumin,0.1
total colonoscopy with ileocecal valve intubation,0.85
brittany towers,0.0
centri.daily.48h/off,0.0
histopathological examination of biopsies of an anatomical structure with mapping,0.65
induced currents,0.0
therapeutic actions,0.1
family history of hepatobiliary and pancreatic diseases,0.1
histopathological examination of staged biopsies from 2 anatomical structures,0.65
dilation of a colonic and/or rectal stenosis by endoscopy,0.85
"infliximab - remsima, 120 mg/1 ml inj pen",1.0
sigmoidoscopy,0.85
partial colonoscopy beyond the sigmoid colon,0.75
modulen ibd box 400g,0.85
pharmacy,0.0
biopsy for biological analysis during a diagnostic endoscopy of the digestive tract,0.85
arthropathy in crohn's disease (k50-$),0.1
dilation of an ileal stenosis by ileoscopy,0.75
comment 9tgnp,0.0
6-thioguanine pediatric,0.25
"total colonoscopy with visualization of the cecal base, without crossing the ileocecal valve",0.85
"total colectomy with rectal preservation, without restoration of continuity, by laparoscopy or laparotomy with preparation by laparoscopy",0.85
biopsy and/or cytological brushing of the digestive tract wall or biliopancreatic duct during a diagnostic endoscopy,0.75
"para-aminosalicylic acid 2 g (quadrasa), powder for rectal solution, bottle 4.2 g",0.85
"complete exploration of the colon after right colectomy, by endoscopy",0.25
ileal enteroscopy [ileoscopy],0.25
covid ibd prot day 0,0.5
ibd covid monitoring,0.3
centrifuge,0.0
picosulfurate,0.1
"ustekinumab - stelara, 130 mg/26 ml inj",0.85
fecal calprotectin,0.85
interpretation,0.0
arthropathy in ulcerative colitis (k51-$) - ankle and foot joints,1.0
tpmt gene conclusion,0.1
tpmt nota bene: tpmt please note,0.0
tpmt therapeutics,0.2
mici cov prot exit,0.1
prot itac d5-d42,0.1
"adalimumab - amgevita, 40 mg/0.8 ml pen",0.85
coloration and/or tattooing of the digestive tract wall during diagnostic endoscopy,0.25
histopathological examination of biopsy of 3 anatomical structures,0.25
histopathological examination of staged biopsies from 3 anatomical structures,0.65
pr chap ifb(1purp),0.0
genetic analysis,0.2
juvenile arthritis in crohn's disease (k50-$) - site unspecified,0.1
anatomopathological examination of intestinal resection specimen for chronic inflammatory bowel disease [ibd],0.85
rigid tube rectoscopy,0.75
palindromic rheumatism,0.1
"secondary proctectomy by laparoscopy with ileoanal anastomosis via the transanal route, after initial total colectomy",1.0
"secondary proctectomy by laparotomy with transanal ileoanal anastomosis, after initial total colectomy",1.0
dilation or incision of anorectal stenosis,0.75
presence of intestinal diversion and anastomosis,0.65
ambient temperature: 22°<48hours-20°c,0.0
centrifugal,0.0
anti-infliximab antibodies,0.75
"total colectomy without restoration of continuity, by laparoscopy or laparotomy with preparation by laparoscopy",0.85
itac inclusion protocol,0.0
prot itac stools,0.2
"total colectomy with ileoanal anastomosis, by laparoscopy or by laparotomy with preparation by laparoscopy",1.0
confirmed pregnancy,0.0
pala154thr,0.0
ptyr240cys,0.0
pala80pro,0.0
cmv pcr/biopsy,0.2
prot prom9535 v1>7,0.0
prot reprevio v3 4 5,0.0
histopathological examination for cancer purposes of endoscopic resection specimen of 1 or 2 lesions of the colon and/or rectum,0.65
"intermittent hydarthrosis - hip, sacroiliac joints",0.1
calprotectin stl-mcnc,0.25
construction of an ileal or colonic reservoir during an ileoanal or coloanal anastomosis,0.85
histopathological examination of biopsy of 2 anatomical structures,0.3
enteric/fecal pcr,0.25
enteric/liquid pcr,0.1
enteric/stool pcr,0.25
ileoconduit,0.2
colonoscopy,0.75
stool,0.2
enteric/secretory pcr,0.2
fecal bag,0.75
intraoperative colonoscopy,0.25
enteric/biopsy pcr,0.3
stool chemistry,0.2
rectal tube,0.25
mucinex,0.0
enteric pcr test,0.25
enteric/lba pcr,0.2
stool pcr,0.2
enteric/liquid biopsy pcr,0.25
stool consistency,0.25
enteric/plasma pcr,0.2
schedule colonoscopy,0.75
laparoscopic enterostomy,0.25
"microscopic colitis, unspecified",0.25
stool color,0.1
enteric anus pcr,0.2
smog enema,0.1
enteric/eco2 pcr,0.1
"proctolog, cream",0.2
stool culture,0.25
stool management,0.65
endoscopy,0.75
expallgttca,0.0
dysport,0.0
stool appearance,0.25
rectal suppository,0.65
urinary oligosaccharides,0.05
inflammatory bowel disease with mcc,0.85
constulose,0.1
exp decision,0.0
eastern information,0.0
organic chemistry,0.0
enteric/environmental pcr 2,0.2
Enterovirus identified,0.05
infuvite,0.1
oligosaccharides - urine,0.05
Escherichia coli DNA,0.1
ibd sgi diagnostic,0.85
id° ena,0.0
egd,0.25
ucu2,0.0
etco2,0.0
organic valley,0.0
oral mucositis (ulcerative),0.25
gastroenteritis and colitis of unspecified origin,0.65
megacomquant,0.0
megacom1qual,0.0
"esophagitis, gastroenteritis and miscellaneous digestive disorders with mcc",0.25
irritable bowel syndrome with mixed bowel habits [ibs-m],0.25
gastrointestinal obstruction with cc,0.25
"urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure",0.0
"systemic inflammatory response syndrome, unspecified",0.2
"urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure",0.05
xucu,0.0
uncomplicated peptic ulcer with mcc,0.1
mni,0.0
acid maltase (acid alpha glucosidase) (pompe disease),0.0
"cardiac catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure",0.0
"gastroenteritis and colitis of infectious origin, other and unspecified",0.25
behcet's interpretation,0.1
l,0.0
title,0.0
fve title,0.0
neutrophil,0.1
bacteria,0.1
cholelithiasis,0.05
gastrointestinal pathogen,0.25
i,0.0
sepsis,0.2
lymphocyte,0.1
gout,0.0
clostridium difficile toxin,0.4
ercp,0.1
see below,0.0
section,0.0
cholelithiasis and cholecystitis,0.05
s comment,0.0
**hapt,0.0
other,0.1
0.4,0.0
hemorrhoidal,0.1
t comment,0.0
elim na,0.0
p comment,0.0
ostomy,0.65
nomenclature,0.0
report,0.0
dr+ g- ul,0.1
prelim u/s,0.1
to,0.0
sodium sulfite,0.0
protocol description,0.0
diagnosis,0.75
c26 0,0.0
asthma,0.05
urate,0.0
kappa,0.0
non-pressure chronic ulcer of buttock with other specified severity,0.1
chronic ulcer of leg or foot,0.1
"colon and/or rectum lesion destruction session with laser, by rectosigmoidoscopy or by partial colonoscopy",0.85
"colon and/or rectum lesion destruction session without laser, by rectosigmoidoscopy or by partial colonoscopy",0.75
"colon and/or rectum lesion destruction session with laser, by total colonoscopy",0.85
gastrointestinal hemorrhage with cc,0.65
"colon and/or rectum lesion destruction session without laser, by total colonoscopy",0.85
laparoscopic cutaneous colostomy,0.25
sucralfate,0.25
presence of a colostomy,0.3
therapeutic colotomy by laparotomy,0.65
non-pressure chronic ulcer of back with other specified severity,0.05
non-pressure chronic ulcer of skin of other sites with other specified severity,0.1
"cutaneous colostomy, by laparotomy",0.25
"excision of 1 to 3 polyps less than 1cm in diameter from the colon and/or rectum, by rectosigmoidoscopy or partial colonoscopy",0.65
"colon lesion hemostasis with laser, by total colonoscopy",0.65
"excision of 1 to 3 polyps less than 1cm in diameter from the colon and/or rectum, by total colonoscopy",0.65
"rectocolic mucosectomy session, by endoscopy",0.85
other specified functional intestinal disorders,0.25
chronic inflammatory pelvic disease,0.1
lesions of stomach and duodenum,0.1
candidal esophagitis,0.1
other digestive system complications,0.5
"rectocolic resection with retrorectal colic lowering by laparotomy, with colorectal anastomosis via the anal route",0.85
"excision of a polyp larger than 1cm in diameter or of 4 or more polyps from the colon and/or rectum, by rectosigmoidoscopy or by partial colonoscopy",0.65
"excision of a polyp larger than 1cm in diameter or of 4 or more polyps from the colon and/or rectum, by total colonoscopy",0.65
adenomatous polyp,0.2
colostomy status,0.3
colyte,0.25
vulvovaginal ulceration and inflammation in diseases classified elsewhere,0.2
"left colectomy with release of the left colic angle, with restoration of continuity, by laparotomy",0.85
"laparoscopic or open rectosigmoid resection with laparoscopic preparation, with coloanal anastomosis through the anal route",0.85
"hemostasis of colon lesion with laser, by rectosigmoidoscopy or by partial colonoscopy",0.75
prot itac biopsy,0.25
aminosalicylic acid,0.25
prucalopride,0.2
miglitol,0.05
propantheline,0.1
alosetron,0.85
small bowel capsule endoscopy,0.25
intestinal bypass and anastomosis status,0.25
Microsporidia DNA,0.1
methylnaltrexone,0.1
nicotine polacrilex,0.05
ova and parasites report,0.1
etanercept,0.25
tissue transglutaminase iga,0.1
vitamin a,0.05
ascorbic acid,0.05
ascorbic acid / ferrous sulfate / folic acid,0.1
ciprofloxacin ophthalmic product,0.0
miconazole / zinc oxide topical product,0.05
alpha tocopherol / ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / docusate / ferrous fumarate / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin b12 / zinc oxide,0.1
cyclosporine,0.85
ciprofloxacin otic product,0.05
ascorbic acid / copper gluconate / docosahexaenoate / eicosapentaenoate / lutein / vitamin e / zeaxanthin / zinc oxide,0.1
2 ml gentamicin 10 mg/ml injection,0.0
polymyxin b / trimethoprim,0.1
50 ml gentamicin 2 mg/ml injection,0.05
sample nature,0.0
chloramphenicol,0.1
alpha tocopherol / ascorbic acid / biotin / cholecalciferol / dexpanthenol / folic acid / niacinamide / pyridoxine / riboflavin / thiamine / vitamin a / vitamin b12 / vitamin k1,0.05
2 ml gentamicin 40 mg/ml injection,0.05
cipro,0.1
ascorbic acid / biotin / folic acid / niacin / pantothenate / pyridoxine / riboflavin / thiamine / vitamin b12,0.05
inosine,0.0
mitrazol,0.1
micro-guard,0.0
miconazole nitrate 20 mg/ml topical cream,0.05
ciprofloxacin 250 mg oral tablet,0.2
gentamicin ophthalmic product,0.0
boric acid,0.0
100 ml ciprofloxacin 2 mg/ml injection,0.1
50 ml gentamicin 1.6 mg/ml injection,0.05
riboflavin,0.01
miconazole nitrate 0.02 mg/mg topical powder,0.05
ciprofloxacin 3 mg/ml ophthalmic solution,0.0
polymyxin b / trimethoprim ophthalmic product,0.0
ofloxacin ophthalmic product,0.0
hydrogen peroxide topical product,0.05
zeasorb,0.0
miconazole topical product,0.0
ofloxacin otic product,0.05
gentamicin topical product,0.1
ascorbic acid / ferrous fumarate / folic acid / vitamin b12,0.1
ascorbic acid / beta carotene / cuprous oxide / lutein / sodium selenate / vitamin e / zinc oxide,0.05
ascorbic acid / polysaccharide iron complex,0.1
ascorbic acid / ferrous fumarate,0.1
"cyclosporine, modified",0.85
bacitracin / polymyxin b,0.1
ascorbic acid / biotin / folic acid / mecobalamin / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine,0.05
ascorbic acid / cuprous oxide / lutein / vitamin e / zinc oxide,0.0
commentary,0.0
ascorbic acid / beta carotene / cuprous oxide / vitamin e / zinc oxide,0.05
ascorbic acid 35 mg/ml / cholecalciferol 0.01 mg/ml / vitamin a 0.45 mg/ml oral solution,0.05
ascorbic acid / ferrous fumarate / folic acid / liver stomach concentrate / vitamin b12,0.05
magnesium oxide,0.1
ascorbic acid / folic acid / iron carbonyl / vitamin b12,0.1
nephrocaps,0.0
neoral,0.2
ascorbic acid 500 mg oral tablet,0.05
ascorbic acid / beta carotene / calcium carbonate / cholecalciferol / cupric oxide / docusate / folic acid / iron carbonyl / magnesium oxide / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b12 / vitamin e / zinc oxide,0.1
ascorbic acid / iron carbonyl,0.1
"heparin sodium, porcine 10 unt/ml prefilled syringe",0.05
cysteamine,0.05
ascorbic acid / d-biotin / folic acid / niacinamide / pantothenate / pyridoxine / riboflavin / thiamine / vitamin b12,0.1
ascorbic acid / bacillus coagulans / cranberry preparation,0.1
"heparin sodium, porcine 10000 unt/ml injectable solution",0.05
lifitegrast,0.1
ascorbic acid / niacin,0.05
ascorbic acid / cranberry preparation,0.1
activase,0.0
cyclosporine ophthalmic product,0.1
glucose / heparin,0.0
acetylcysteine 200 mg/ml inhalation solution,0.05
vitamin a/vitamin d,0.1
sandimmune,0.1
"500 ml heparin sodium, porcine 2 unt/ml injection",0.0
"250 ml heparin sodium, porcine 100 unt/ml injection",0.05
sodium,0.05
heparin,0.05
acetic acid / antipyrine / benzocaine / policosanol otic product,0.0
rapamune,0.1
dexpanthenol,0.1
ascorbic acid / cranberry preparation / lactobacillus sporogenes,0.1
"heparin sodium, porcine 1000 unt/ml injectable solution",0.05
acetylcysteine,0.05
hydrogen peroxide,0.0
polymyxin b,0.05
ascorbic acid/bioflavonoids,0.05
ciprofloxacin,0.1
acetic acid,0.1
lactate,0.1
cholecalciferol,0.05
bioc b-mol (1lill),0.0
reserpine,0.05
magnesium citrate,0.1
atropine,0.05
acarbose,0.05
sirolimus,0.1
steatorrhea,0.65
tpmt genotyping (thiopurine methyltransferase),0.25
acetoacetyl-saccharomyces cerevisiae,0.05
toulouse (1purp),0.0
day 3: weight,0.1
"iron deficiency anemias, unspecified or not due to blood loss",0.65
biopsy localization,0.2
anesthesia,0.05
oxybutynin chloride,0.1
anaplastic lymphoma,0.0
eculizumab,0.1
"lymphocyte immune globulin, anti-thymocyte globulin, equine",0.1
myasthenia gravis,0.0
calcium,0.05
"lymphocyte immune globulin, anti-thymocyte globulin",0.1
hydroxyurea,0.1
calcium gluconate,0.05
caffeine,0.0
hydroxocobalamin,0.05
ivermectin,0.0
"hyoscyamine / methenamine / methylene blue / sodium phosphate, monobasic",0.1
benzoate / hyoscyamine / methenamine / methylene blue / phenyl salicylate,0.1
vitamin e,0.05
epinephrine,0.05
benzocaine,0.05
alemtuzumab,0.75
drugs identified,0.1
carbon dioxide,0.05
caffeine citrate 20 mg/ml oral solution,0.0
bismuth subcitrate / metronidazole / tetracycline,0.1
gamma globulin,0.1
diclofenac,0.2
reticulocytes,0.1
cafcit,0.0
alanine / arginine / aspartate / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine,0.0
erythrocytes.nucleated/100 leukocytes,0.05
baricitinib,0.75
alanine / arginine / glucose / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine,0.0
3 ml caffeine citrate 20 mg/ml injection,0.0
cholesterol.total/cholesterol.in hdl,0.0
caffeine / ergotamine,0.0
diclofenac / misoprostol,0.25
"hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic",0.2
prealbumin,0.1
benzoate / caffeine,0.0
apremilast,0.1
leflunomide,0.2
1 ml naloxone hydrochloride 0.4 mg/ml injection,0.0
2 ml naloxone hydrochloride 1 mg/ml prefilled syringe,0.0
naloxone / pentazocine,0.05
suboxone,0.05
amyl nitrite,0.05
alanine / arginine / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / threonine / tryptophan / tyrosine / valine,0.0
cytomegalovirus dna,0.1
alanine aminotransferase,0.1
protamines,0.0
protein/creatinine,0.1
total protein,0.1
andexanet alfa,0.05
estramustine,0.05
physostigmine,0.05
10 ml calcium gluconate 100 mg/ml injection,0.0
creatinine dialysis fluid clearance,0.05
amlodipine,0.0
methylene blue,0.2
idarucizumab,0.05
aspirin- and butalbital- and caffeine-containing product,0.05
protein fractions,0.05
amlodipine / valsartan,0.0
tau protein,0.05
influenza,0.0
erythrocytes,0.05
Creatinine/body weight,0.1
25-hydroxyvitamin d2,0.05
phentolamine,0.05
platelets large,0.05
amlodipine / atorvastatin,0.0
ofloxacin,0.1
flumazenil,0.0
folic acid,0.1
citric acid,0.0
Platelets reticulated,0.05
mitotane,0.05
duration,0.0
oxybate,0.0
total cholesterol,0.05
oliguria and anuria,0.1
abnormal results of function study of kidney,0.05
testosterone,0.0
magnesium chloride,0.1
hyperparathyroidism,0.0
time 3,0.0
copper,0.0
anion gap,0.1
disorders of porphyrin metabolism,0.05
nitisinone,0.0
phenylbutyrate,0.1
measured ca++,0.1
total bilirubin,0.1
primary angle-closure glaucoma,0.0
chylomicrons,0.05
Sodium/Creatinine,0.1
varicella zoster virus dna,0.05
nailfold capillaroscopy,0.05
thiosulfate,0.05
time 1,0.85
ethanol,0.0
appearance,0.0
abatacept,0.25
potassium,0.1
cryptococcus sp ag,0.05
urine osmolality,0.05
Biotinidase,0.0
deoxyhemoglobin/hemoglobin.total,0.1
manual differential comment,0.0
Calcium/Phosphate,0.05
myoglobin,0.0
hepatitis c virus ab,0.05
glucose-6-phosphate dehydrogenase,0.05
cardiogenic shock,0.0
esomeprazole / naproxen,0.2
hemoglobin a1c,0.05
lymphoid leukemia,0.0
beta 2 globulin,0.1
myeloid leukemia,0.0
creatinine - random urine,0.1
Normoblasts/100 leukocytes,0.05
prothrombin time (pt),0.1
vitamin b6,0.05
bone marrow or stem cell transplant,0.1
oxygen saturation,0.05
oxygen content,0.05
disorders of parathyroid gland,0.0
danaparoid,0.1
"aceclofenac (cartex) 100 mg myl, tab",0.1
rheumatoid factor,0.05
ph bldcoa,0.0
platelet mean volume,0.1
creatinine -24 hr urine*neutrophils,0.05
famotidine / ibuprofen,0.1
diuresis,0.1
user,0.85
troponin i.cardiac,0.0
troponin t,0.0
oxalate,0.1
alpha 1 globulin/protein.total,0.1
naproxen / sumatriptan,0.05
natalizumab,0.25
everolimus,0.1
ionized calcium,0.05
urea,0.0
chlorine,0.0
upadacitinib,0.85
belimumab,0.1
thymoglobulin,0.05
mycophenolic acid 360 mg delayed release oral tablet,0.2
siponimod,0.0
conclusion,0.0
biotin,0.05
cladribine,0.1
partial pressure of carbon dioxide in tissues,0.05
rabbit anti-human t-lymphocyte globulin,0.1
Blood,0.0
cyclopentolate,0.0
ph temp adj bldc,0.0
belatacept,0.1
partial pressure of oxygen,0.0
cell counts+differential studies,0.2
patient temperature,0.05
hct vfr.df bldv,0.0
total co2,0.1
po2 bldcoa,0.0
tissue oxygen partial pressure,0.05
o2 saturation measurement,0.05
0.4 ml enoxaparin sodium 100 mg/ml prefilled syringe,0.05
pco2 bldcoa,0.0
oxyhemoglobin,0.05
bicarbonates,0.05
base excess,0.1
uric acid,0.05
tetracaine,0.05
potassium blda-scnc,0.05
excess base ecf,0.1
biological validation,0.0
barometric pressure,0.0
result,0.85
inspired oxygen fraction (fio2),0.05
deoxyhemoglobin,0.05
glucose bld-scnc,0.05
carboxyhemoglobin,0.05
measured hemoglobin,0.2
clinical information,0.85
selenium,0.0
"hiv infection, symptomatic",0.0
other disorders of liver,0.1
tuberculosis,0.05
viral infection,0.05
thrombocytopenia,0.25
endocarditis,0.05
human immunodeficiency virus [hiv] disease,0.0
poisoning by psychotropic agents,0.0
hypoglycemia,0.05
alcohol-related disorders,0.05
urinary tract infection,0.0
non-hodgkins lymphoma,0.05
pleurisy; pleural effusion,0.05
adverse drug events and drug allergies,0.2
meningitis,0.0
bacterial infection nos,0.2
infectious and parasitic complications affecting pregnancy,0.05
convulsions,0.05
edema,0.25
anticoagulants causing adverse effects,0.1
decreased white blood cell count,0.25
pericarditis,0.05
herpes simplex,0.0
coronary atherosclerosis,0.0
pyogenic arthritis,0.05
hyperlipidemia,0.05
type 2 diabetes,0.05
calculus of kidney,0.0
contusion,0.0
shock,0.05
psychosis,0.05
erectile dysfunction [ed],0.05
vitamin b-complex deficiencies,0.2
intestinal disaccharidase deficiencies and disaccharide malabsorption,0.1
cataract,0.0
frequency of urination and polyuria,0.1
postoperative infection,0.1
sickle cell anemia,0.0
empyema and pneumothorax,0.0
congestive heart failure (chf) nos,0.0
complication of internal orthopedic device,0.05
"malignant neoplasm of liver, primary",0.0
cancer of esophagus,0.0
other hemoglobinopathies,0.05
complication of amputation stump,0.0
septicemia,0.2
urinary calculus,0.0
pulmonary insufficiency or respiratory failure following trauma and surgery,0.0
cough,0.0
chronic sinusitis,0.05
atopic/contact dermatitis due to other or unspecified,0.0
ascites (non malignant),0.2
other venous embolism and thrombosis,0.05
congenital anomalies of skin,0.0
thyroid cancer,0.0
cerebrovascular disease,0.0
hydrocephalus,0.0
calculus of ureter,0.0
hydronephrosis,0.05
pulmonary congestion and hypostasis,0.0
epilepsy,0.0
diabetes or abnormal glucose tolerance complicating pregnancy,0.05
cerebral aneurysm,0.0
disorders of magnesium metabolism,0.1
viral hepatitis c,0.05
pruritus and related conditions,0.2
fracture of foot,0.0
streptococcus infection,0.05
essential hypertension,0.05
effects radiation nos,0.05
methotrexate,0.75
sulfamethoxazole,0.2
hemorrhage nos,0.45
diaper or napkin rash,0.05
disorders of the autonomic nervous system,0.1
other nutritional deficiency,0.25
other findings,0.1
unspecified erythematous condition,0.2
disorders of copper metabolism,0.05
prednisolone,0.85
hypopotassemia,0.25
asphyxia and hypoxemia,0.05
iddm patient ql,0.1
urokinase,0.0
platelets,0.1
methemoglobin,0.05
oxygen,0.05
leukocyte esterase,0.1
alteplase,0.0
Urea/Creatinine,0.1
"heparin, porcine",0.05
total nk mm,0.0
cd16 mm,0.0
patient facs lt#,0.0
cd56 mm,0.05
cd45ro/ra+cd3 percent,0.05
ra + cd62l + cd8 normal control percent,0.05
cd10 normal control percent,0.0
cd56 normal control percent,0.05
cd45ro+cd3 normal control percent,0.05
lymph sum normal control,0.05
cd20 percent,0.0
cd3+ti gb  mm,0.05
ra+cd62l+cd3 percent,0.05
cd3+cd4:cd3+cd8 ratio,0.05
cd45 mm,0.0
cd20 mm,0.0
patient absolute lymphs,0.1
patient wbc,0.1
cd2 percent,0.0
cd45+cd14+ normalcontrol percent,0.05
cd45+cd14+ percent,0.05
ra + cd62l + cd8 percent,0.1
cd45ro+cd3 percent,0.05
patient percent lymphs,0.1
ra+cd62l+cd4 normal control percent,0.05
occult blood panel,0.25
ra+cd62l+cd3 mm,0.0
total nk percent,0.0
cd16 percent,0.0
cd56 percent,0.0
cd3+cd8 percent,0.05
ra + cd62l + cd8mm,0.05
cd3+cd8 mm,0.1
cd45ra+cd3 mm,0.1
ra+cd62l+cd4 percent,0.05
cd45ra+cd3 percent,0.05
ra+cd62l+cd4 mm,0.1
cd3+cd4 percent,0.1
cd3 mm,0.0
cd3 percent,0.0
cd3+cd4 mm,0.1
cd2 mm,0.0
cd3+ti ab percent,0.05
cd3+ti ab mm,0.1
index 1,1.0
abdominal aorta and lower extremity arteriography by transcutaneous lumbar intra-aortic injection,0.05
adverse effect: psychostimulants subject to abuse,0.05
other disorders of carbohydrate transport and metabolism,0.05
adverse effect: oxazolidinediones,0.1
myopathy,0.05
"adverse effect: vaccine or biological substance, unspecified",0.1
pemphigus and pemphigoid,0.05
"sodium alginate+sodium bicarbonate 250 mg+133.5 mg/5 ml (gaviscon), oral susp, bottle 250 ml",0.1
breast cancer,0.0
"placement of an intraperitoneal catheter for peritoneal dialysis, via transcutaneous route",0.05
pathology,0.2
adverse effect: h2 histamine receptor inhibitor,0.25
polymyositis,0.05
serum proteins,0.1
"sphincterotomy of the minor duodenal papilla [accessory papilla], by esophagogastroduodenoscopy",0.05
"intrarenal stone fragmentation with shock waves or laser [intrarenal lithotripsy], by ureteronephroscopy",0.0
cystic fibrosis,0.0
"unilateral or bilateral removal of a ureteral stent, by retrograde endoscopy",0.1
removal of an implanted infusion system and intraventricular or intracystic cerebral catheter,0.0
motorcycle passenger - transport accident - non-collision - off-road,0.0
alcohol intoxication and exposure to alcohol (ethanol) - unspecified place,0.0
reference markers,0.0
total ablation of pelvic organ reinforcement mesh implant by laparoscopy,0.1
obesity,0.1
"resection or consolidation of an infarcted myocardial zone, by thoracotomy with cpb",0.0
narrative diagnostic report,0.0
temporary authorization for use,0.0
iliac ureter stone removal and/or fragmentation by retrograde ureteroscopy,0.0
magnesium / calcium,0.05
"poisoning by psychotropic substances, unspecified - school and public place",0.0
"adverse effect: barbiturates, nec",0.05
intravenous administration of pharmacological agent and/or solute in the newborn at birth,0.05
other disorders of the breast associated with childbirth and disorders of lactation,0.0
peritoneal lavage with insertion of an intraperitoneal catheter via a transcutaneous route,0.1
magnesium/calcium,0.05
calcium/oxalate,0.1
antibiotics,0.2
"parenteral nutrition: oliclinomel n4-550, 1.5 l bag",0.25
lupus (localized and systemic),0.05
chromosomal anomalies,0.05
anterior and posterior nasal packing,0.0
"ethinylestradiol+cyproterone 35 mcg+2 mg (diane 35 mcg), tablet",0.05
fractional flow reserve (ffr) measurement during coronary angiography,0.0
lumbar ureteral stone removal by laparoscopy or retroperitoneoscopy,0.05
anti-double-stranded dna,0.05
fetal distress and abnormal forces of labor,0.0
adverse effect: inhaled anesthetics,0.0
proteins,0.0
a1 microglob urine,0.05
circulatory disease nec,0.05
see clinical and biological assessment,0.1
chromosomal anomalies and genetic disorders,0.05
jo-1 extractable nuclear ab,0.1
lubiprostone,0.25
discharge orders,0.1
parasite search,0.1
biopsy of lesion of the perianal region and/or anal canal,0.65
polys,0.05
context,0.0
"mental and behavioral disorders due to acute intoxication: volatile solvents, delirium",0.0
"adverse effect: vitamins, nec",0.05
toxic effect of noxious substances eaten as food,0.1
percutaneous removal of a simple renal calculus,0.0
ketorolac tromethamine,0.1
treatment protocol,0.2
distribution index,0.0
endoscopic removal of stone or foreign body from the bladder,0.0
ca/p,0.0
immuno pc,0.1
laparoscopic suture of intraperitoneal wound or perforation of the rectum,0.75
*igm sg,0.0
preeclampsia and eclampsia,0.0
treatment,0.1
protime and aptt,0.05
U1 small nuclear ribonucleoprotein Ab,0.1
calcium carbonate / magnesium carbonate,0.1
rigid urethrocystoscopy,0.05
zinc acetate,0.1
"anastomosis between a pancreatic pseudocyst and the stomach [cystogastrostomy], by laparotomy",0.05
sepsis and sirs,0.2
tiselius index,0.0
hyposmolality and/or hyponatremia,0.25
biochemical ldh,0.05
"intrabronchial instillation of pharmacological agent for therapeutic purposes, by rigid tube bronchoscopy",0.0
nutritional assessment,0.3
monos,0.05
abnormal constituents,0.2
hyperpotassemia,0.2
lymphosarcoma,0.05
acidosis,0.2
p.jiroveci lp/pcr,0.1
cod liver oil,0.05
acute renal failure,0.1
differential (manual),0.1
biochemistry,0.0
number,0.0
nc biochem lab,0.05
istat  specimen type,0.0
secondary gingivoalveolar hemostasis following tooth extraction,0.0
colon radiography with contrast medium opacification,0.85
adverse effect: oral contraceptives,0.05
lactulose 667 mg/ml oral solution,0.2
alkalosis,0.1
disorders of phosphorus metabolism,0.05
mononuclear cell collection by cytapheresis for cell therapy,0.1
praziquantel,0.0
hemolyzed sample,0.0
com enr bio spe,0.1
lymphs,0.1
admission for suspected myocardial infarction,0.0
r.pcr.m.pneumoliq,0.0
systemic sclerosis,0.1
histoplasmosis,0.0
gastroparesis,0.1
kaposi's sarcoma,0.0
ena identification,0.05
tuberculin purified protein derivative,0.05
tenecteplase,0.05
palonosetron,0.1
bariatric surgery,0.1
mupirocin,0.05
plan summary,0.0
other disorders of pancreatic internal secretion,0.05
total ps immuno,0.1
alcoholic liver damage,0.05
chronic hepatitis,0.05
resource,0.0
thalidomide,0.1
lactulose,0.2
pneumonia due to fungus (mycoses),0.05
"parenteral nut: aminomix 800 (e) 1,000 kcal/1 l",0.2
dermatitis herpetiformis,0.1
citric acid / magnesium oxide / picosulfurate,0.1
ciclesonide,0.25
magnesium carbonate,0.1
dok,0.0
magnesium oxide 400 mg oral tablet,0.1
mannitol,0.1
polyethylene glycols / polyvinyl alcohol,0.1
polyethylene glycols,0.2
osmitrol,0.1
megaloblastic anemia,0.2
aluminum hydroxide / magnesium carbonate,0.1
citric acid / gluconolactone / magnesium carbonate,0.05
mood disorders,0.05
uro-mag,0.0
aluminium hydroxide- and magnesium carbonate-containing product,0.1
mag-ox 400,0.05
sorbitol,0.1
"immortal 10 g, powder for oral solution, sachet",0.0
ana pattern,0.1
psychogenic disorder,0.05
minocycline,0.1
typing,0.0
triamcinolone,0.65
cl elimination,0.1
portal hypertension,0.2
pirfenidone,0.0
dimethyl fumarate,0.1
azathioprine 50 mg oral tablet,0.85
temozolomide,0.05
pomalidomide,0.05
polycarbophil-containing product,0.25
ascorbic acid / polyethylene glycol 3350 / potassium chloride / sodium ascorbate / sodium chloride / sodium sulfate,0.2
hydrocodone bitartrate,0.1
magaldrate,0.1
desonide,0.2
pramlintide,0.0
mayo miscellaneous specimen,0.1
acetaminophen / tramadol,0.0
40 ml methotrexate 25 mg/ml injection,0.75
tocilizumab,0.2
radiography of the hemiskelet or the complete skeleton in adults,0.05
multiple cesarean delivery supplement,0.0
control or surveillance ultrasound of fetal or maternal pregnancy pathology during a singleton pregnancy,0.0
"imaging for interventional radiology or interventional cardiology procedure level 1, performed in an imaging room",0.05
supplement for electrocardiography performed at the patient's home,0.0
subfascial subcutaneous injection of autologous adipose tissue in the face,0.0
mediastinal lymph node dissection supplement during pneumonectomy or lobectomy,0.0
"imaging for interventional radiology or interventional cardiology procedure level 9, performed in an imaging room",0.05
"imaging for interventional radiology or interventional cardiology procedure level 15, performed in an imaging room",0.05
supplement for specific examination prior and subsequent to the fitting of a mandibular advancement device in the treatment of obstructive sleep apnea-hypopnea syndrome,0.0
intraoperative injection supplement of radiological contrast agent into the biliopancreatic ducts for radiographic imaging,0.05
intraoperative intracarotid injection supplement of radiological contrast agent for arteriography,0.0
"imaging for interventional radiology or interventional cardiology procedure level 3, performed in an imaging room",0.05
supplement for suprapubic injection of contrast medium for cystography,0.05
digital archiving supplement for a mammography or a ct or mri scan,0.0
supplement for performing a radiographic examination with digitized images,0.05
contact irradiation for malignant disease,0.0
"complete venous radiological assessment of the lower limbs for complex venous pathology requiring multiple approaches, possible tourniquet applications, and imaging in different positions",0.0
ovulation induction with gonadotropins followed by artificial insemination or in vitro fertilization,0.0
irradiation in cyclotron therapy by accelerator in fractions of 2 grays for beams of 5 to 7.9 mev,0.0
"imaging for interventional radiology or interventional cardiology procedure level 7, performed in an imaging room",0.05
"ultrasound and/or doppler ultrasound for monitoring or surveillance of pathology of one or two intra-abdominal and/or intrapelvic organs, or peripheral vessels",0.1
"imaging for interventional radiology or interventional cardiology procedure level 21, performed in an imaging room",0.05
"imaging for interventional radiology or interventional cardiology procedure level 8, performed in an imaging room",0.05
contrast media supplement for intrathecal injection,0.05
"first-line treatment of cases requiring technical procedures (intravenous infusion, oxygen administration, cardio-respiratory resuscitation care, etc.) and prolonged presence of the physician (outside of a healthcare facility) in the following situations: - respiratory distress; - cardiac distress; - allergic distress; - acute state of agitation; - status epilepticus; - traumatic distress.",0.05
irradiation of less than 300 cm² in fixed fields by telecobalt per fraction of 28 centigrays for beams of 0.5 to 4.9 mev,0.05
"imaging for interventional radiology or interventional cardiology procedure level 4, performed in an imaging room",0.05
pre- and postoperative fixation or reduction device for maxillary or mandibular resection or graft,0.0
resuscitation package level 1,0.0
supplement for radiological examination of the gallbladder and bile ducts and/or pancreatic during a diagnostic or therapeutic procedure,0.05
ultrasound guidance,0.1
resuscitation package level a,0.0
mediastinal lymph node dissection supplement during a mediastinal surgery act,0.0
"imaging for interventional radiology or interventional cardiology procedure level 19, performed in an imaging room",0.05
contrast medium injection supplement for hip arthrography,0.0
supplement for imaging for interventional radiology procedure performed in the operating room,0.05
ct-guided navigation,0.05
supplement for histopathological diagnosis of malignant tumor lesions,0.1
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 12 grays for beams of 17 to 24.9 mev,0.05
"imaging for interventional radiology or interventional cardiology procedure level 2, performed in an imaging room",0.05
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 1.4 grays for beams of 8 to 16.9 mev,0.05
"sperm retrieval from the testicle, epididymis, or vas deferens, by direct approach",0.0
"imaging for interventional radiology or interventional cardiology procedure level 22, performed in an imaging room",0.05
cardiology package level 1,0.0
blood gas analysis supplement during level 3 pulmonary function testing,0.05
supplement for histopathological diagnosis of tumor lesions,0.1
intravenous contrast material injection supplement during a radiographic or ct examination,0.2
supplement for intraoperative sampling and placement of bone autograft away from the surgical site,0.0
supplement for the use of custom and focused caches,0.0
contrast media injection supplement for retrograde urethrocystography,0.0
magnesium sulfate,0.1
ocean brand of sodium chloride,0.0
calcium chloride,0.0
calcium chloride 0.001 meq/ml / glucose 50 mg/ml / potassium chloride 0.004 meq/ml / sodium chloride 0.103 meq/ml / sodium lactate 0.028 meq/ml injectable solution,0.05
150 ml sodium chloride 9 mg/ml injection,0.05
sodium bicarbonate,0.1
alanine / arginine / aspartate / cysteine / glutamate / glycine / histidine / isoleucine / leucine / lysine / methionine / phenylalanine / proline / serine / sodium acetate / sodium chloride / sodium metabisulfite / taurine / threonine / tryptophan / tyrosine / valine,0.0
zinc sulfate,0.1
sodium acetate,0.05
100 ml potassium chloride 0.1 meq/ml injection,0.05
sodium chloride 0.0769 meq/ml,0.0
glucose / potassium chloride / sodium chloride,0.05
control or surveillance ultrasound of fetal or maternal pregnancy pathology during a multifetal pregnancy,0.0
"supplement for the performance of a radiological examination by a mountain doctor during the diagnostic and therapeutic management of a traumatic bone and joint, musculotendinous, or soft tissue injury at the same time.",0.0
50 ml magnesium sulfate 40 mg/ml injection,0.1
calcium chloride / magnesium chloride / potassium chloride / sodium acetate / sodium chloride / sodium citrate,0.05
polyethylene glycol 3350 / potassium chloride / sodium bicarbonate / sodium chloride / sodium sulfate,0.25
potassium acetate / potassium bicarbonate / potassium citrate,0.1
calcium chloride / icodextrin / lactate / magnesium chloride / sodium chloride,0.0
"supplement for the use of cinefluorography, in 35 mm during a conventional radiology examination",0.0
potassium chloride 20 meq extended release oral tablet,0.1
sodium chloride,0.05
alanine / arginine / calcium chloride / dibasic potassium phosphate / glucose / glycine / histidine / isoleucine / leucine / lysine / magnesium chloride / methionine / phenylalanine / proline / serine / sodium acetate / sodium chloride / threonine / tryptophan / tyrosine / valine,0.05
potassium chloride,0.1
calcium carbonate / magnesium chloride,0.1
potassium phosphate/sodium phosphate,0.1
supplement for removal of 4 impacted or germinal molars performed in office under local anesthesia,0.0
chromic chloride / copper sulfate / manganese sulfate / selenious acid / zinc sulfate,0.05
deep sea,0.0
klor-con,0.1
1000 ml sodium chloride 9 mg/ml injection,0.05
aspirin / citric acid / sodium bicarbonate,0.05
calcium chloride / magnesium chloride / potassium chloride / sodium acetate / sodium chloride,0.05
supplement for oral and dental procedures for the care of patients with severe disabilities,0.0
10 ml potassium chloride 2 meq/ml injection,0.05
1000 ml potassium chloride 0.02 meq/ml / sodium chloride 9 mg/ml injection,0.05
chromous chloride / copper sulfate / manganese chloride / zinc chloride,0.0
500 ml magnesium sulfate 40 mg/ml injection,0.1
potassium chloride 20 meq powder for oral solution,0.1
50 ml sodium bicarbonate 84 mg/ml prefilled syringe,0.05
moviprep,0.25
glucose / potassium chloride,0.05
potassium acetate,0.1
500 ml sodium chloride 30 mg/ml injection,0.05
omeprazole / sodium bicarbonate,0.2
sodium chloride 1000 mg oral tablet,0.05
50 ml sodium chloride 9 mg/ml injection,0.05
magnesium chloride / potassium chloride / sodium acetate / sodium chloride / sodium gluconate,0.1
calcium chloride 0.0014 meq/ml / glucose 50 mg/ml / potassium chloride 0.024 meq/ml / sodium chloride 0.103 meq/ml / sodium lactate 0.028 meq/ml injectable solution,0.1
calcium chloride / potassium chloride / sodium chloride,0.05
calcium chloride / glucose / lactate / potassium chloride / sodium chloride,0.05
1000 ml glucose 50 mg/ml / potassium chloride 0.02 meq/ml / sodium chloride 9 mg/ml injection,0.05
zinc sulfate 220 mg oral capsule,0.1
clinimix e 5/15,0.05
chromic chloride / copper sulfate / manganese sulfate / zinc sulfate,0.0
calcium chloride / fibrinogen / fibrinolysis inhibitor / thrombin,0.0
1000 ml sodium chloride 4.5 mg/ml injection,0.05
chromous chloride / copper sulfate / manganese sulfate / selenious acid / zinc sulfate,0.0
20 ml potassium chloride 2 meq/ml injection,0.05
citric acid / potassium bicarbonate / sodium bicarbonate,0.05
benzyl alcohol / sodium chloride,0.0
1000 ml glucose 50 mg/ml / potassium chloride 0.04 meq/ml / sodium chloride 9 mg/ml injection,0.1
sodium chloride 30 mg/ml inhalation solution,0.0
trophamine 10 %,0.0
calcium chloride / lactate / potassium chloride / sodium chloride,0.05
glycophos,0.0
calcium carbonate / magnesium oxide / zinc sulfate,0.1
30 ml sodium chloride 234 mg/ml injection,0.05
1000 ml glucose 50 mg/ml / sodium chloride 9 mg/ml injection,0.05
golytely,0.25
100 ml magnesium sulfate 40 mg/ml injection,0.05
nicotine,0.1
fecal electrolytes random (oo),0.25
medrol,0.25
day 2: weight,0.05
"resistance to other antibiotics related to vancomycin, infection situation",0.1
jejunal enteroscopy with ileal enteroscopy,0.65
"ligation of the internal iliac [hypogastric] arteries for postpartum hemorrhage, by laparotomy",0.0
"self-poisoning by narcotics, psychodysleptics nec - collective institution",0.0
"dilation of the path of a percutaneous gastrostomy, with placement of a gastrostomy button",0.1
dexrazoxane,0.0
renin,0.05
"calcium+cholecalciferol 500 mg+400 iu (densical vitamin d3), chewable or sublingual tablets",0.05
"calcium + cholecalciferol 600 mg + 400 iu (natecal vitamin d3), orodispersible tablets",0.1
elastic band ligation of hemorrhoids,0.1
bacterial agents resistant to other antibiotics related to vancomycin,0.1
coronary artery bypass graft (cabg),0.0
"midfoot or forefoot amputation or disarticulation, with hindfoot stabilization",0.0
microcrystal arthropathy in hyperparathyroidism (e21-$),0.05
adverse effect: therapeutic gases,0.05
3 t edta + 3 t hep,0.0
dementia due to multiple drugs and other psychoactive substances,0.0
"sodium alginate sodium bicarbonate 0.5 g/0.267 g biogaran, oral suspension, sachet 10 ml",0.1
aspartate aminotransferase,0.1
alcohol intoxication and exposure - undetermined intent - home,0.0
"pediaven newborn 1, 115 kcal/250 ml ap-hp, solution for infusion, bi-compartment biofine bag",0.05
transcutaneous ultrasound of the digestive tract and/or peritoneum,0.25
laser resection of prostate hypertrophy via urethrocystoscopy,0.0
csf pcr for meningitis,0.05
macrobiopsy of the digestive tract wall during a diagnostic endoscopy,0.75
ureteral dilation by ureterocystoscopy with radiological guidance,0.05
neuronal ceroid lipofuscinosis (ncl 1 -2 -3 -5 -6 -7 - 8),0.0
miglustat,0.05
foreign body left in body - removal of a catheter or packing,0.05
self-poisoning by alcohol and exposure to alcohol - school and public place,0.0
"intrarenal fragmentation of lower caliceal calculus with shock waves or laser [intrarenal lithotripsy], by ureteronephroscopy",0.0
"mobilizing liberation of the tibiotalar joint and/or tibiotalar synovectomy, by arthrotomy",0.0
cycloserine,0.1
"water for injection (labo lavoisier), solution for injection preparation, bottle 250 ml",0.0
"placement of a central catheter in 2 different veins for extracorporeal circulation, via a percutaneous route",0.05
coenzyme q10,0.01
biopsy of the minor salivary glands,0.05
removal of a ureteral stent by retrograde endoscopy,0.05
bladder sphincter re-education session with learning of urinary triggering methods or self-catheterization,0.1
"dpa physioneal 40, ca=1.25, 2.27% glucose, single pouch luer2. 5l (ref rpb5293r)",0.1
a-lc1 blot test,0.1
fecal elastase,0.1
endothel prot j15++,0.0
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 12 centigrays for beams of 17 to 24.9 mev,0.05
supplement for dental surgical care for a patient with a long-term illness and treated with direct oral anticoagulants [doac] or vitamin k antagonists [vka],0.1
quantitative test for pharmacodynamic agents or allergen provocation test involving a measurement of the reactivity threshold,0.1
"imaging for interventional radiology or interventional cardiology procedure level 11, performed in an imaging room",0.05
performance of an electroencephalography during an endo-thoracic surgery or neurosurgery intervention,0.0
"imaging for interventional radiology or interventional cardiology procedure level 20, performed in an imaging room",0.05
resuscitation package level b,0.0
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 20 grays for beams of 5 to 7.9 mev,0.05
catheterization and injection of radiological contrast agent into the lacrimal ducts supplement,0.0
"single breath, rebreathing, or breath-hold carbon monoxide transfer measurement in the steady state",0.05
supplement for intrauterine injection of radiological contrast agent or medicinal substance,0.0
residual volume measurement supplement during standard spirometry,0.0
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 20 centigrays for beams of 5 to 7.9 mev,0.05
supplement for performing an electroencephalography act at home or in a facility without electroencephalographic equipment,0.0
20 ml sodium acetate 2 meq/ml injection,0.05
100 ml sodium chloride 9 mg/ml injection,0.05
supplement for the use of a recording and verification system of parameters,0.0
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 1.2 grays for beams of 17 to 24.9 mev,0.05
sodium chloride 9 mg/ml injection,0.05
potassium chloride 10 meq extended release oral tablet,0.1
leukocytes other,0.1
kay ciel,0.0
tailorx protocol follow-up,0.0
whole-body dual-energy x-ray absorptiometry (dxa) for constitutional bone disease in children,0.05
"imaging for interventional radiology or interventional cardiology procedure level 12, performed in an imaging room",0.05
intraoperative somatosensory evoked potential monitoring during spinal surgery,0.0
intraoperative radiography supplement during an orthopedic or trauma surgery procedure,0.0
intensive care level 2 package,0.1
irradiation of less than 300 cm² in fixed fields by accelerator per fraction of 2 grays for beams of 5 to 7.9 mev,0.05
colposcopy completion supplement,0.0
hyperbaric oxygen therapy session,0.05
micturating study supplement during a urethrocystography,0.05
contact radiotherapy treatment protocol for malignant disease,0.0
irradiation in cyclotron therapy by accelerator in fractions of 20 centigrays for beams of 5 to 7.9 mev,0.05
citric acid / simethicone / sodium bicarbonate,0.1
50 ml potassium chloride 0.4 meq/ml injection,0.05
sodium phosphate,0.1
ammonium chloride,0.05
sodium bicarbonate 650 mg oral tablet,0.1
10 ml calcium chloride 100 mg/ml prefilled syringe,0.0
dexpanthenol / magnesium sulfate / manganese sulfate / niacinamide / pyridoxine / riboflavin / thiamine / vitamin b 12 / zinc sulfate,0.05
"sodium phosphate / sodium phosphate, monobasic",0.1
250 ml sodium chloride 9 mg/ml injection,0.0
potassium chloride / sodium chloride,0.1
zinc chloride,0.0
atropine / hyoscyamine / phenobarbital / scopolamine,0.1
"lidocaine/chlorhexidine - instillagel lido 2%, urethral gel",0.05
migraine,0.0
placement of an intraperitoneal catheter with placement of an implantable subcutaneous infusion system for intraperitoneal insulin therapy,0.05
myelography with ct scan of the spinal column [myelo-ct],0.05
transcutaneous ultrasound and rectal and/or vaginal [cavity] ultrasound of the bladder,0.1
protozoan infection,0.1
"calcium+cholecalciferol 500 mg+400 iu (calcium vitamin d3 lab arrow), chewable or lozenge tablets",0.05
"closure of a traumatic arteriovenous fistula of the lower limb without vascular reconstruction, by direct approach",0.0
observation for suspected mental and behavioral disorders,0.0
"poisoning by psychotropic drugs, nec - other specified places",0.0
Calcium/Oxalate,0.1
sulfate,0.0
bethanechol,0.1
cellcept,0.25
calcium polycarbophil,0.2
cystic kidney disease,0.0
thrombopoietin (tpo) assay - serum and/or plasma,0.05
fosfomycin,0.1
viral hepatitis,0.05
ceruloplasmin,0.05
laboratory - chemistry and hematology,0.1
neutrophils/100 leukocytes,0.1
cryoproteins,0.1
iga.lambda,0.05
iga.kappa,0.05
cystatin c,0.05
mannose-binding protein,0.1
white blood cell count,0.1
erythropoietin,0.1
dimension,0.0
xifaxan,0.2
doxycycline,0.1
monocytes,0.1
colistin / hydrocortisone / neomycin / thonzonium,0.25
linaclotide,0.75
paregoric,0.2
rotavirus antigen report,0.05
radiological guidance,0.1
"imaging for interventional radiology or interventional cardiology procedure level 5, performed in an imaging room",0.05
"diagnostic and therapeutic management at the same time of a traumatic bone-joint, musculotendinous, or soft tissue lesion",0.0
supplement for use of individual restraints,0.0
"attempted angioplasty of a coronary vessel, subclavian artery, visceral or peripheral, in case of failure to cross the stenosis",0.0
intraoperative blood salvage supplement,0.05
"imaging for interventional radiology or interventional cardiology procedure level 13, performed in an imaging room",0.05
supplement for intraoperative harvesting of saphenous vein autograft,0.0
participation of a second surgeon during a cardiac surgery act,0.0
sodium glycerophosphate,0.05
50 ml sodium bicarbonate 84 mg/ml injection,0.05
1000 ml glucose 50 mg/ml / potassium chloride 0.04 meq/ml / sodium chloride 4.5 mg/ml injection,0.05
sodium chloride nasal product,0.0
cd45ro/ra+cd3 mm,0.1
cd45ro+cd3 mm,0.1
cd40 normal control percent,0.0
total nk normal control percent,0.0
cd3+cd4 normal control percent,0.05
cd3+ti ab normal control percent,0.05
calcium carbonate,0.05
"risankizumab 90 mg (skyrizi), inj sol, syr 1 ml",0.85
risankizumab - skyrizi 300mg (90mg/ml) iv inf. sol. vial (eap),0.85
"trimébutine 200 mg biogaran, tablets",0.1
"mebeverine 200 mg zydus, tablets",0.1
unilateral or bilateral radiography of the temporomandibular joint,0.0
"poisoning by other specified bio substances, undetermined intent - school and public area",0.0
"electronic monitoring of the contractions of the pregnant uterus and/or fetal heart rate, via the uterine route",0.0
percutaneous puncture of the kidney cavities with ultrasound guidance,0.0
purpura and other hemorrhagic conditions,0.1
tiopronin,0.1
oxalate/creatinine ratio,0.1
congenital disorder of glycosylation type ic,0.05
chronic bronchitis,0.0
chymotrypsin,0.05
tryptase,0.05
lipoprotein associated phospholipase a2,0.05
pyruvate kinase,0.05
Acetylcholinesterase,0.05
angiotensin converting enzyme,0.05
cachexia,0.25
lysozyme,0.1
sevelamer,0.1
5'-nucleotidase,0.05
cholinesterase,0.05
"parenteral nut: aminomix 800 (e) bag 1,500 kcal/1.5 l",0.1
Rotavirus RNA,0.05
co (picco),0.0
necroinflammatory activity interpretation,0.25
ciprofloxacin / hydrocortisone,0.65
relistor,0.1
mucoprotein/creatinine,0.1
neuroendocrine tumors,0.05
"yersinia culture, stool report",0.2
"stool examination, qualitative",0.25
sapovirus pcr,0.05
ms/ms creatinine (mm),0.1
prednisone 10 mg oral tablet,0.75
prednisone 20 mg oral tablet,0.75
astrovirus pcr,0.05
Cryptosporidium sp Ag,0.1
"ova and parasites,3 specimens",0.2
noro research,0.0
cyclic citrullinated peptide antibody,0.1
acetohydroxamic acid,0.1
invert sugar,0.0
ethanolamine oleate,0.05
sector/area,0.0
Microorganism identified,0.2
colesevelam,0.2
fecal ionophore,0.05
"culture, stool",0.25
doxercalciferol,0.1
succinate,0.0
composition,0.0
endoscopic exploration of an intestinal neobladder,0.1
enterococcus,0.1
senokot,0.1
paricalcitol,0.1
origin,0.0
organic acids,0.1
erythromycin,0.1
etelcalcetide,0.0
organic bile salts,0.1
irrigation sleeve,0.1
Eosinophils/100 cells,0.1
urinal,0.0
"docusate / sennosides, usp",0.2
polystyrene sulfonate,0.2
polidocanol,0.1
absolute eosinophil count,0.1
tegaserod,0.1
adnic,0.0
automated eosinophil count,0.1
plecanatide,0.2
specimen weight,0.05
renvela,0.1
automated eosinophil percentage,0.1
"injection, aflibercept, 1 mg, ziv-aflibercept",0.1
monocyte lymphocyte count,0.2
immature granulocytes,0.1
total protein and neutrophil count,0.2
synovial fluid white blood cells,0.1
Lymphocytes/100 cells,0.1
mononucleosis cell count,0.05
respiratory culture,0.05
basophils,0.05
eosinophils/basophils,0.1
total lymphocytes,0.2
pregnancy associated plasma protein a,0.05
endoscopic detorsion of a colonic volvulus,0.25
"leukocytes, stool report",0.65
stool guaiac,0.25
stool sodium,0.1
lymphocyte count,0.2
rectal tumor excision via the anal route,0.25
"rectosigmoid resection for congenital aganglionosis with restoration of continuity, via the anal route",0.1
anorectal manometry,0.25
hev/pcr stool,0.2
colon rectal surg schedule surgery,0.65
"rectosigmoid resection with infraperitoneal colorectal anastomosis, by laparotomy",0.85
stool weight,0.25
"rectosigmoid resection extending beyond the douglas pouch, without restoration of continuity, by laparotomy",0.85
transsphincteric approach for rectal tumor excision,0.2
"resection of an acquired rectovaginal fistula, with one-stage closure by muscle suture and advancement flap, via perineal approach",0.75
stool guaiac qc,0.25
jejunoscopy,0.25
hemofiltration supplement during cpb monitoring,0.0
obstetric unit monitoring of a child requiring incubator care or short-term treatment,0.0
hyperbaric treatment with doctor outside the chamber,0.05
5 ml lidocaine hydrochloride 20 mg/ml prefilled syringe,0.05
"oxybuprocaine, 1.6 mg single-dose eye drops",0.0
proparacaine hydrochloride 5 mg/ml ophthalmic solution,0.0
lidocaine / prilocaine,0.05
lidocaine topical product,0.1
lidocaine / prilocaine topical product,0.1
lidocaine 25 mg/ml / prilocaine 25 mg/ml topical cream,0.05
clinimix e 4.25/5,0.0
potassium lactate,0.1
"destruction of tracheobronchial tree lesion with laser, by fibroscopy",0.0
autologous breast reconstruction with pedicled musculocutaneous flap from the autologous latissimus dorsi muscle [ald [autologous latissimus dorsi]] without placement of a prosthetic implant,0.0
"partial cystectomy with ureterovesical reimplantation, by laparotomy",0.1
"total cystectomy with cutaneous transintestinal ureterostomy using a continent detubularized loop, by laparotomy",0.1
potassium iodide,0.0
glycopyrrolate,0.1
rigid bronchoscopy with transbronchial needle aspiration of mediastinal lesions,0.0
"resection of prostate hypertrophy, by urethrocystoscopy",0.0
bendamustine,0.1
lomefloxacin,0.1
sevelamer carbonate,0.1
tapentadol,0.1
oxybutynin,0.05
acetaminophen / dexbrompheniramine,0.0
Cryptosporidium sp DNA,0.1
vancomycin 250mg 5ml susp,0.2
cranioplasty material removal from the vault,0.0
=morphine,0.05
lymph absolute value,0.1
hematology lab nc,0.1
polymorphonuclear leukocytes,0.25
mycoses,0.05
hip synovectomy by arthrotomy with two approaches including a posterior approach,0.0
c difficile toxin a & b reflex,0.25
bmthr gene panel,0.1
monocytic leukemia,0.0
hyperchylomicronemia,0.05
monocytes nfr mar manual,0.1
psoriatic arthropathy,0.1
material continuity diagram,0.0
small bowel transplant post-op lab set,0.1
Interleukin 1 beta,0.25
rimexolone,0.1
prednisone 1 mg oral tablet,0.25
"altim 3.75 mg/1.5 ml, srg",0.1
other gastrointestinal diagnostic procedures,0.25
viscosity,0.05
arthroscopy,0.0
dna double strand,0.0
esophageal dilatation,0.1
nepafenac,0.05
enalaprilat,0.05
oj ab,0.0
urethral discharge,0.05
colistimethate,0.1
ethacrynic acid,0.1
acidophilus,0.1
specimen source,0.1
cervical cancer and dysplasia,0.0
arthrocentesis,0.05
dental caries,0.0
codeine,0.05
clue cells,0.1
cellulose,0.0
chronic interstitial cystitis,0.05
docusate,0.2
talc,0.0
iga,0.0
dissociative disorder,0.0
glossitis,0.1
unspec urine ca (group:u/uca),0.05
unspec urine un (group:u/uun),0.05
acute febrile mucocutaneous lymph node syndrome (kawasaki disease),0.05
chronic pancreatitis,0.05
atherosclerosis of native arteries of the extremities with ulceration or gangrene,0.05
thyroiditis,0.0
bronchitis,0.0
iodine,0.0
granulocytes,0.1
bile acid,0.1
appendectomy,0.1
fasciitis,0.05
toxoplasma gondii,0.0
helicobacter pylori ag,0.1
gangrene,0.05
babesia duncani ab,0.0
igg,0.0
wegener's granulomatosis,0.05
gluten ige,0.05
chlamydia trachomatis,0.0
systemic lupus erythematosus,0.05
hodgkin's disease,0.0
fluorouracil,0.2
leukemia,0.0
carcinoid syndrome,0.05
celecoxib,0.1
abscess or ulceration of vulva,0.1
cyclic citrullinated peptide ab,0.1
local excision of large intestine lesion (not endoscopic),0.75
salicylates,0.75
inflammatory diseases of female pelvic organs,0.1
cholelithiasis with other cholecystitis,0.0
cyclic citrullinated peptide igg,0.05
inflammatory diseases of prostate,0.05
sacroiliitis nec,0.1
bronchiectasis,0.0
reiter's disease,0.2
chronic cystitis,0.05
ciliated columnar lining cells/100 leukocytes,0.1
salicylic acid,0.1
cholelithiasis with acute cholecystitis,0.0
obstructive chronic bronchitis,0.0
inflammatory disease of breast,0.0
juvenile rheumatoid arthritis,0.0
persistent vomiting,0.25
sevelamer hydrochloride,0.1
carboprost tromethamine,0.05
rheumatoid arthritis and other inflammatory polyarthropathies,0.1
gastrin,0.1
secukinumab,0.1
abnormality of secretion of glucagon or gastrin,0.1
coal tar,0.1
dyspepsia and other specified disorders of function of stomach,0.1
valve,0.0
connector,0.0
colorectal screening test,0.25
urine color,0.05
medication organizer,0.0
absolute immunoglobulin count,0.1
eosinophil absolute count,0.2
diaper,0.05
e-z-cat,0.0
easivent,0.0
filter,0.0
lancet,0.0
other chronic nonalcoholic liver disease,0.1
aloe vera preparation,0.1
"reservoir,minimed",0.0
metoclopramide,0.2
succimer,0.05
urine sediment comments,0.0
Oligosaccharides pattern,0.1
Disaccharidases,0.1
immune complex,0.1
intramuscular immunoglobulin,0.1
reticulin iga,0.1
rotavirus vaccine,0.0
costochondritis,0.05
saccharide,0.0
Artifact,0.0
yeast,0.0
hypersensitivity angiitis,0.1
acute sinusitis,0.0
ill-defined descriptions and complications of heart disease,0.0
infectious mononucleosis,0.0
allergic rhinitis,0.0
urethritis and urethral syndrome,0.05
graft-versus-host disease,0.1
multiple sclerosis,0.0
systemic inflammatory response syndrome (sirs),0.2
peritoneal or intestinal adhesions,0.25
infusion and transfusion reaction,0.05
lactose,0.05
bcg,0.1
Iodine/Creatinine,0.05
autoimmune disease nec,0.25
helicobacter pylori ab,0.1
aspergillosis,0.0
neutrophil ab,0.1
bullous dermatoses,0.05
Curvularia IgE,0.05
other pulmonary inflamation or edema,0.0
salicylates causing adverse effects in therapeutic use,0.25
bismuth subsalicylate,0.25
h. pylori,0.1
other or gastrointestinal therapeutic procedures,0.65
rosacea,0.0
"complications of gastrostomy, colostomy and enterostomy",0.2
nonallopathic lesions nec,0.1
colloidal oatmeal topical product,0.1
helicobacter pylori iga,0.1
cholecystitis without cholelithiasis,0.05
coal tar topical product,0.2
canakinumab,0.75
helicobacter pylori igm,0.1
Busulfan,0.1
acetic acid / hydrocortisone,0.75
carisoprodol,0.0
chemistry studies,0.1
interleukin 6,0.25
citrate,0.0
=enalaprilat,0.0
ed,0.0
environmental culture,0.05
ocuvitetablet,0.0
uibc,0.0
urine culture,0.05
nocharge,0.0
"reducing substances, feces",0.2
empty capsul cap siz,0.0
tens unit,0.05
pump_enteral,0.2
"cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure",0.0
"insertion of gastric or duodenal sound as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure",0.1
mast cells,0.1
report status,0.0
"endoscopy, sigmoid",0.75
bacteria identified,0.25
attention to colostomy,0.3
"gastro-esophageal reflux disease with esophagitis, with bleeding",0.1
"esophagitis, unspecified with bleeding",0.1
non-pressure chronic ulcer of skin of other sites with bone involvement without evidence of necrosis,0.05
clotest for h.pylori,0.1
other esophagitis with bleeding,0.2
other cholangitis,0.05
colonoscopy high risk; colon cancer screening,0.65
consult / referral to colon and rectal surgery,0.75
osteo/rheum medication authorization,0.1
"intestinal adhesions [bands], with partial obstruction",0.2
urine protein electrophoresis: total volume,0.05
arg external,0.0
asa external,0.05
absolute retic,0.05
poc sed rate,0.1
ige allergen crab,0.05
epres,0.0
eddp quantitative,0.0
val external,0.0
poc act celite,0.0
ipres,0.0
ige  allergen pecan,0.05
eating disorder,0.05
volume,0.0
dysplasia of cervix,0.0
water,0.0
rals comment,0.0
contracture of joint,0.05
infective connective tissue disorders,0.1
ige allergen latex,0.0
camphor,0.0
ige allergen ovalbumin,0.05
dislocation,0.0
cervicalgia,0.0
drvvt,0.0
wash motility,0.1
conduct disorders,0.0
neo irt external,0.0
poc creatinine,0.1
prostatitis,0.05
urine total volume,0.05
diseases of esophagus,0.1
ige allergen helminthospore,0.05
osteochondropathies,0.05
galt external,0.0
eosinophil %,0.1
intem clot time,0.0
phi,0.0
urethral hypermobility/isd,0.05
intem maximum clot firmness,0.0
osteomyelitis,0.05
aortic valve disease,0.0
herpes zoster,0.0
atherosclerosis,0.05
scleritis and episcleritis,0.1
transplant liver portal inflammation,0.1
"malignant neoplasm of small intestine, including duodenum",0.05
obstruction of bile duct,0.05
acute and subacute necrosis of liver,0.05
chronic laryngitis,0.0
postinflammatory pulmonary fibrosis,0.1
antineoplastic and immunosuppressive drugs causing adverse effects,0.25
noninflammatory disorders of cervix,0.0
magnesium aspartate / potassium aspartate,0.05
bacitracin / hydrocortisone / neomycin / polymyxin b,0.1
ciprofloxacin / dexamethasone,0.25
dexamethasone / neomycin / polymyxin b,0.2
hydrocortisone / neomycin / polymyxin b,0.25
hypercalcemia,0.1
dexamethasone / tobramycin,0.1
hydrocortisone / iodoquinol,0.65
nystatin / triamcinolone,0.1
citric acid / potassium citrate / sodium citrate,0.05
viral hepatitis a,0.0
pityriasis,0.05
total cd25*+,0.1
synovitis and tenosynovitis,0.1
colcrys,0.1
invanz,0.1
or urine,0.0
aggrenox,0.0
actos,0.0
emend injection,0.1
cleocin,0.1
etoh,0.05
procrit,0.1
rfxucu,0.0
cco pac,0.0
eag,0.0
ric infiltration scale,0.0
constitutional,0.05
alternagel,0.1
creon,0.1
avapro,0.1
transitional epithelial cells,0.1
vented,0.0
or sent,0.85
d5ns,0.0
dilantin,0.0
renagel,0.05
art lumen volume,0.05
d5lr,0.0
activity,0.0
bowel sounds,0.1
gi prophy,0.1
lue color,0.0
c. diff pcr,0.65
advair,0.0
integrilin,0.05
urine source,0.0
catapres,0.05
or ebl,0.0
peco2,0.0
rozerem,0.0
rle color,0.0
spiriva,0.0
nasal congestion,0.0
pan1,0.0
gastrointestinal obstruction without cc/mcc,0.2
respiratory infections and inflammations with mcc,0.05
flatus,0.2
cam-icu ms change,0.1
azactam,0.0
critically ill,0.1
kidney and urinary tract infections with mcc,0.05
"myeloid leukemia, acute",0.0
transient cerebral ischemia,0.0
major gastrointestinal disorders and peritoneal infections with cc,0.25
gastrointestinal hemorrhage with mcc,0.65
"surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation",0.2
rue sensation,0.0
"other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure",0.05
"radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure",0.1
cam-icu rass loc,0.0
unasyn,0.1
interventional radiology,0.1
isentress,0.0
allegra,0.0
"blood, occult",0.25
acute pharyngitis,0.0
aphasia/speech disturbance,0.0
nausea and vomiting (ciwa),0.2
anal and stomal procedures with mcc,0.65
stricture/obstruction of ureter,0.05
lr,0.0
response,0.85
assistance,0.0
h,0.0
wbc,0.1
gi #1 intub site,0.1
neisseria gonorrhoeae,0.0
hemodialysis,0.05
nitric oxide,0.1
commands,0.0
renal dialysis,0.05
endometriosis,0.05
aortic aneurysm,0.0
pyelonephritis,0.05
gi #3 intub site,0.1
pressure ulcer present,0.1
carafate (sucralfate),0.75
pressure ulcer stage #7,0.0
pressure ulcer stage #8,0.0
other digestive system diagnoses with mcc,0.5
pressure ulcer stage #2,0.1
pressure ulcer stage #10,0.1
pressure ulcer stage #5,0.05
pressure ulcer stage #6,0.0
pressure ulcer stage #9,0.05
pressure ulcer #2- stage,0.1
pressure ulcer stage #3,0.1
pressure ulcer stage #4,0.1
chronic obstructive pulmonary disease with cc,0.0
pressure ulcer #2- type,0.1
pressure ulcer #5- stage,0.1
pressure ulcer #5- type,0.1
pressure ulcer #3- stage,0.1
pressure ulcer #3- type,0.1
pressure ulcer #6- stage,0.1
pressure ulcer #2- length,0.1
sucralfate 1000 mg oral tablet,0.65
pressure ulcer #4- length,0.1
pressure ulcer #6- type,0.1
pressure ulcer #5- length,0.1
pressure ulcer #4- type,0.1
pressure ulcer #4- stage,0.1
pressure ulcer #6- length,0.1
pressure ulcer #3- length,0.1
cirrhosis and alcoholic hepatitis with mcc,0.05
pressure ulcer #2- tunneling present,0.1
proctozone hc,0.85
pressure ulcer #2- cleanse,0.1
pressure ulcer #3- cleanse,0.1
pressure ulcer #1- stage,0.1
pressure ulcer #5- tunneling present,0.1
solu-cortef,0.25
cortef,0.2
miralax,0.2
bisacodyl 5 mg delayed release oral tablet,0.1
polyethylene glycol 3350 17000 mg powder for oral solution,0.25
t tube,0.1
"sennosides, usp 8.6 mg oral tablet",0.1
absolute lymphocyte count,0.1
dexamethasone phosphate 10 mg/ml injectable solution,0.25
hydrocortisone 10 mg/ml topical cream,0.2
dexamethasone 0.5 mg oral tablet,0.25
prednisolone acetate 10 mg/ml ophthalmic suspension,0.05
triamcinolone acetonide 1 mg/ml topical cream,0.1
hydrocortisone 20 mg oral tablet,0.75
triamcinolone acetonide 0.001 mg/mg topical ointment,0.1
prednisone 2.5 mg oral tablet,0.75
methylprednisolone 40 mg injection,0.65
solu-medrol,0.65
prednisone 5 mg oral tablet,0.75
prednisone 50 mg oral tablet,0.75
methylprednisolone 62.5 mg/ml injectable solution,0.25
methylprednisolone 125 mg injection,0.75
tubersol,0.0
1 ml dexamethasone phosphate 4 mg/ml injection,0.25
dexamethasone 2 mg oral tablet,0.25
"sennosides, usp 1.76 mg/ml oral solution",0.1
loperamide hydrochloride 0.2 mg/ml oral solution,0.25
progress,0.0
methadone hydrochloride 2 mg/ml oral solution,0.1
"protein, total",0.05
endoscopic retrograde cannulation of pancreas (ercp),0.05
bisacodyl 10 mg rectal suppository,0.25
oddibil,0.0
wormwood,0.0
rennes station,0.0
organic farming,0.0
fecal nitrogen,0.1
elimination round,0.0
nc ech immuno,0.05
acidurique,0.0
elim citrate,0.0
aicardi,0.0
cmpo,0.0
elimination chamber,0.0
"colon exsufflation, by endoscopy",0.65
undifferentiated %,0.1
fecal aat clearance,0.2
urine,0.0
eosinophilic liquid biopsy,0.1
aspect,0.0
ethyl oxide,0.0
e5 dog,0.0
nc ech,0.0
anca-associated,0.25
cells,0.0
see attached file,0.0
% lymphocytes,0.1
info 3,0.0
bile acids,0.1
mucopolysaccharides,0.05
nomenclature 4,0.0
immunology,0.1
algosteril dressing on the ulcer,0.2
"diversion ileocolostomy [ileocolic anastomosis without intestinal resection], by laparotomy",0.65
"left colectomy with release of the left colic angle, without restoration of continuity, by laparotomy",0.85
"hemostasis of colon lesion without laser, by rectosigmoidoscopy or by partial colonoscopy",0.65
"other disorders of the digestive system following diagnostic and therapeutic procedures, nec",0.2
"secondary restoration of digestive continuity after colectomy, by laparoscopy",0.75
"hemostasis of colon lesion without laser, by total colonoscopy",0.75
"rectosigmoid resection by laparotomy, with coloanal anastomosis via the anal route or by transsphincteric approach",0.85
carcinological purpose anatomopathological examination of total coloproctectomy specimen,0.85
protective enterostomy or cutaneous colostomy during intestinal resection with restoration of continuity,0.75
"intestinal lesion hemostasis without laser, by ileoscopy",0.75
"left colectomy without release of the left colic angle, with restoration of continuity, by laparotomy",0.85
"complete resection of an exteriorized colorectal prolapse, with coloanal anastomosis and pelvic floor myorrhaphy",0.25
"left colectomy with release of the left colic angle, with restoration of continuity, by laparoscopy or laparotomy with preparation by laparoscopy",0.85
"submucosal dissection of rectal lesion, by endoscopy",0.65
interleukin 6 il6 - serum,0.25
"closure of cutaneous enterostomy, by direct approach",0.25
nutritional way,0.1
capsaicin / lidocaine / menthol / methyl salicylate,0.05
lidocaine,0.1
cd20 normal control percent,0.05
cd45ro/ra+cd3 normal control percent,0.05
cd2 normal control percent,0.0
cd19 normal control percent,0.0
cd3 normal control percent,0.0
cd16 normal control percent,0.0
cd3+ti gd percent,0.05
cd3+cd4:cd3+cd8 ratio normal control,0.05
cd3+cd8 normal control percent,0.05
ra+cd62l+cd3 normal conrtol percent,0.05
cd45ra+cd3 normal control percent,0.05
cd3+ti gd normal control percent,0.05
lidocaine / menthol,0.05
dibucaine,0.1
"somatostatin, 6 mg/1 ml inj",0.1
nutritional marasmus,0.1
octreotide,0.25
trandolapril,0.1
enalapril,0.05
enalapril maleate 10 mg oral tablet,0.1
lisinopril 20 mg oral tablet,0.0
moexipril,0.0
ramipril,0.1
enalapril maleate 5 mg oral tablet,0.1
lisinopril 5 mg oral tablet,0.0
lisinopril 10 mg oral tablet,0.0
captopril 25 mg oral tablet,0.0
accupril,0.0
quinapril,0.1
lisinopril 2.5 mg oral tablet,0.0
capoten,0.0
captopril 12.5 mg oral tablet,0.0
"zofenil (zofenopril) 15 mg, tablet",0.0
"tanatril (imidapril) 10 mg, tab",0.0
"cilazapril 2.5 mg teva, tablets",0.0
perindopril,0.0
lisinopril,0.0
fosinopril,0.0
benazepril,0.05
lanreotide,0.1
1 ml octreotide 0.1 mg/ml injection,0.1
1 ml octreotide 0.5 mg/ml injection,0.1
pasireotide,0.1
captopril,0.05
atenolol,0.0
triazolam,0.0
"nitrazepam - mogadon, 5 mg scored tablet",0.0
"havlane 1 mg, tablet",0.0
"rohypnol 1 mg, tablets",0.0
24-hour urine output,0.1
nimodipine,0.0
leukocyte morphology finding,0.1
intravenous injection of a cellular therapy product for autograft,0.05
red blood cell concentrate transfusion of a volume less than half a blood mass,0.1
red blood cell transfusion at home,0.2
intravenous injection of a cellular therapy product for allograft,0.05
exchange transfusion in the newborn,0.0
red blood cell concentrate transfusion of a volume greater than half the blood mass during surgery under general or regional anesthesia,0.1
non-erythrocyte labile blood product transfusion,0.1
red blood cell concentrate transfusion of a volume less than 40 ml/kg in the newborn,0.05
red blood cell concentrate transfusion of a volume greater than one half blood mass in adults or 40 milliliters per kilogram [ml/kg] in newborns in less than 24 hours.,0.1
"simultaneous intravenous administration of two of the following blood products: fresh frozen plasma, platelets, antihemophilic factor, fibrinogen, antithrombin iii for coagulopathy replacement, per 24 hours.",0.05
transfusion of non-red blood cell labile blood products in the newborn,0.05
exchange transfusion,0.05
amlodipine / olmesartan,0.0
calcium chloride / glucose / lactate / magnesium chloride / sodium chloride,0.05
glucose / sodium chloride,0.05
"magnesium chloride / potassium chloride / potassium phosphate / sodium acetate / sodium chloride / sodium gluconate / sodium phosphate, dibasic",0.1
eluxadoline,0.2
nontraumatic compartment syndrome,0.0
cholestyramine resin 4000 mg powder for oral suspension,0.2
prot regain inclusio,0.0
coagulation defects,0.1
acquired hemolytic anemias,0.1
congenital factor viii disorder,0.0
pyruvate,0.0
intraoperative injection supplement of radiological contrast agent into the urinary tract for radiographic imaging,0.05
encephalitis,0.0
"medical stabilization and monitoring of a newborn for medical transfer to a specialized center, with a report preparation",0.0
gamma globulin/protein.total,0.1
hemorrhagic disorder due to intrinsic circulating anticoagulants,0.05
"pre-birth pediatric assistance on call by the practitioner in charge of the delivery for a neonatal risk situation, with a report being made",0.0
"immediate or delayed resuscitation of the newborn in life-threatening distress, involving any ventilation technique, with or without intubation, and associated procedures, with a report being made",0.0
congenital coagulation defects,0.0
Monocytes/100 cells,0.1
c peptide,0.05
gonococcal infections,0.0
"imaging for interventional radiology or interventional cardiology procedure level 16, performed in an imaging room",0.05
=nafcillin,0.0
prob,0.0
ndc required ,0.0
"other vascular catheterization, not heart",0.0
incision and excision of cns,0.0
diagnostic ultrasound of heart (echocardiogram),0.0
diagnostic spinal tap,0.05
conversion of cardiac rhythm,0.0
other therapeutic endocrine procedures,0.05
bunionectomy or repair of toe deformities,0.0
therapeutic radiology,0.1
mammography,0.0
embolectomy and endarterectomy of lower limbs,0.0
"diagnostic cardiac catheterization, coronary arteriography",0.0
"other or therapeutic procedures, male genital",0.05
ureteral catheterization,0.05
"endarterectomy, vessel of head and neck",0.0
nephrotomy and nephrostomy,0.05
electrographic cardiac monitoring,0.05
"hysterectomy, abdominal and vaginal",0.05
other or therapeutic procedures on bone,0.0
"incision of pleura, thoracentesis, chest drainage",0.05
"diagnostic procedures on nose, mouth and pharynx",0.05
other non-or therapeutic procedures on musculoskeletal system,0.0
"transurethral excision, drainage, or removal urinary obstruction",0.05
other diagnostic cardiovascular procedures,0.0
"treatment, facial fracture or dislocation",0.0
"treatment, fracture or dislocation of hip and femur",0.0
"treatment, fracture or dislocation of lower extremity (other than hip or femur)",0.0
intraoperative cholangiogram,0.0
cerebral arteriogram,0.0
insertion of catheter or spinal stimulator and injection into spinal canal,0.05
arterio- or venogram (not heart and head),0.05
extracorporeal circulation auxiliary to open heart procedures,0.0
other non-or therapeutic procedures on respiratory system,0.0
arterial blood gases,0.1
electroencephalogram (eeg),0.0
cardiac stress tests,0.0
diagnostic bronchoscopy and biopsy of bronchus,0.0
swan-ganz catheterization for monitoring,0.05
other therapeutic procedures on muscles and tendons,0.05
"laminectomy, excision intervertebral disc",0.0
endoscopy and endoscopic biopsy of the urinary tract,0.0
bone marrow biopsy,0.05
gastric bypass and volume reduction,0.1
other or procedures on vessels other than head and neck,0.05
other non-or therapeutic procedures of urinary tract,0.05
"gastrostomy, temporary and permanent",0.2
blood transfusion,0.1
mastectomy,0.0
partial excision bone,0.0
other or procedures on vessels of head and neck,0.0
respiratory intubation and mechanical ventilation,0.05
other or therapeutic procedures on skin and breast,0.0
"thyroidectomy, partial or complete",0.0
ct scan chest,0.05
"gastrectomy, partial and total",0.2
"extracorporeal lithotripsy, urinary",0.0
alcohol and drug rehabilitation/detoxification,0.0
myelogram,0.05
decompression peripheral nerve,0.0
routine chest x-ray,0.05
"aortic resection, replacement or anastomosis",0.05
prophylactic vaccinations and inoculations,0.05
lens and cataract procedures,0.0
other or heart procedures,0.0
"insertion, revision, replacement, removal of cardiac pacemaker or cardioverter/defibrillator",0.0
contrast arteriogram of femoral and lower extremity arteries,0.05
percutaneous transluminal coronary angioplasty (ptca),0.0
arthroplasty knee,0.0
"hip replacement, total and partial",0.0
heart valve procedures,0.0
"oophorectomy, unilateral and bilateral",0.0
magnetic resonance imaging,0.25
"insertion, replacement, or removal of extracranial ventricular shunt",0.0
amputation of lower extremity,0.0
"tracheostomy, temporary and permanent",0.0
spinal fusion,0.0
bone marrow transplant,0.05
other diagnostic procedures on musculoskeletal system,0.0
"incision and drainage, skin and subcutaneous tissue",0.05
other or therapeutic procedures of urinary tract,0.05
"debridement of wound, infection or burn",0.05
destruction of lesion of retina and choroid,0.0
cholecystectomy and common duct exploration,0.0
biopsy of liver,0.1
"calcium, total",0.05
cholecalciferol 0.025 mg oral tablet,0.05
"excision, lysis peritoneal adhesions",0.1
"bilateral total arthrectomy and/or posterior osteotomy for rigid spinal deformity with arthrodesis, instrumental correction, and anterior transpedicular osteotomy, on 6 to 9 vertebrae, via posterior approach",0.0
miconazole,0.05
abdominal paracentesis,0.25
igm,0.0
nordiazepam,0.0
other hernia repair,0.0
morphine,0.1
lactate dehydrogenase,0.1
other or upper gi therapeutic procedures,0.65
alpha-1-fetoprotein,0.05
lithium,0.05
peritoneal dialysis,0.05
choriogonadotropin (pregnancy test),0.0
parathyrin.intact,0.0
methemoglobin/hemoglobin.total,0.1
aldosterone,0.05
digoxin,0.0
transurethral resection of prostate (turp),0.0
6-monoacetylmorphine,0.0
immunoglobulin light chains.kappa/immunoglobulin light chains.lambda,0.1
prolactin,0.05
oxazepam,0.05
granular casts,0.1
osmolality,0.1
choriogonadotropin.beta subunit (pregnancy test),0.0
thyrotropin,0.0
electrocardiogram,0.0
oxymorphone,0.05
tacrolimus,0.65
oxycodone,0.05
25-hydroxyvitamin d3,0.05
thyroxine,0.0
thyroxine free,0.0
other non-or gastrointestinal therapeutic procedures,0.2
"imaging for interventional radiology or interventional cardiology procedure level 17, performed in an imaging room",0.05
other therapeutic procedures,0.25
"microscopic examination (bacterial smear, culture, toxicology)",0.2
generic code,0.1
laboratory comment,0.0
fluorescein / proparacaine,0.0
Prealbumin/Protein.total,0.1
other laboratory,0.1
free cortisol,0.1
medications,0.25
forms,0.0
kit,0.0
specimen site,0.1
small bowel series with contrast ingestion,0.25
miscellaneous information,0.0
tube,0.0
ana extended immunology panel,0.1
need authorization,0.0
therapy,0.1
galactose 1 phosphate uridyl transferase,0.0
creatine kinase,0.05
controlled substance agreement,0.0
drug and medication abuse rehabilitation,0.0
maprotiline,0.1
delirium due to conditions classified elsewhere,0.1
fever of unknown origin,0.2
colonoscopy not high risk; colon cancer screening,0.25
cologuard colon cancer screen,0.1
rectal muscle biopsy via the anal route,0.75
sodium sulfate,0.1
consult / referral to gastrointestinal surgery,0.75
encounter for attention to colostomy,0.3
spot5mlsyringe5mlsyr,0.0
consult / referral to gastroenterology,0.75
magnesium hydroxide,0.1
chlamydia trachomatis+neisseria gonorrhoeae dna,0.0
clamp,0.0
bag,0.0
xanthochromia,0.05
"injection, mepolizumab, 1 mg",0.1
pyrazinamide,0.0
specimen condition,0.05
prosource plus,0.0
medical match notes and comments,0.85
matrix,0.0
trimethoprim+sulfamethoxazole,0.1
bisacodyl,0.1
didemethylcital,0.0
desmethylcital,0.0
citalopram,0.1
mayo refrigerated specimen,0.05
antimicrobial,0.2
imipenem/cilastatin,0.1
cyclospora cayetanensis polymerase chain reaction,0.1
pentamidine,0.05
celiac m title,0.1
meropenem,0.05
placement of a bowel bag in a newborn at birth,0.1
plasmacytic lineage,0.1
misc charge,0.0
bioch nutri (1purp),0.1
gen surg mck schedule surgery,0.1
calcitonin,0.05
bacterial agents resistant to one other specified antibiotic,0.1
encounter for surgical aftercare following surgery on the digestive system,0.65
"right colectomy with restoration of continuity, by laparotomy",0.75
"right colectomy with continuity restoration, by laparoscopy or laparotomy with preparation by laparoscopy",0.85
"right colectomy without restoration of continuity, by laparotomy",0.75
msi pcr,0.1
"resection of adhesions and/or peritoneal bands for acute intestinal obstruction, by laparotomy",0.2
mg/creat ratio,0.05
intestinal cutaneous stoma revision by laparotomy,0.65
thioguanine,0.85
tpmt enzyme activity,0.2
"parenteral nutrition: smofkabiven (e), 2200kcal/1970ml (tpn)",0.25
total immunoglobulin m,0.1
helicobacter pylori igg,0.1
tedizolid,0.1
adenosine deaminase,0.1
trihexyphenidyl,0.05
orphenadrine,0.05
cefaclor,0.0
orphenadrine citrate,0.05
telithromycin,0.1
etodolac,0.1
other and unspecified congenital anomalies,0.05
soybean oil,0.0
antibiotic dosing,0.2
iga exploration m.coel,0.1
tissue transglutaminase igg,0.1
magnesium gluconate,0.1
valdecoxib,0.1
meloxicam,0.25
acute bronchospasm,0.05
nateglinide,0.0
fat,0.0
hydrogen+methane/expired gas,0.1
hydrogen/expired gas,0.0
interpretation (ltt) (group:lttin),0.0
methane/expired gas,0.1
patient symptoms,0.0
endomysium ab,0.1
deprecated s pneum12 igg ser-mcnc,0.0
thyroid cyst,0.0
rifaximin,0.25
corn (zea mays) ige,0.05
deprecated s pneum14 igg ser-mcnc,0.0
calcium carbonate / famotidine / magnesium hydroxide,0.2
turmeric extract,0.1
oral aphthae,0.2
acid alpha glucosidase,0.05
tocopherols,0.05
beef ige,0.0
other disorders of thyroid,0.0
contact dermatitis and other eczema due to plants [except food],0.05
streptococcus pneumoniae danish serotype 9v igg,0.0
deprecated s pneum5 igg ser-mcnc,0.0
deprecated s pneum17 igg ser-mcnc,0.05
streptococcus pneumoniae danish serotype 33f igg,0.0
deprecated s pneum43 igg ser-mcnc,0.05
deprecated s pneum2 igg ser-mcnc,0.0
deprecated s pneum34 igg ser-mcnc,0.0
deprecated s pneum20 igg ser-mcnc,0.0
streptococcus pneumoniae danish serotype 19a igg,0.0
streptococcus pneumoniae danish serotype 15b igg,0.05
deprecated s pneum22 igg ser-mcnc,0.05
umbilical hernia,0.0
vertiginous syndromes and other disorders of vestibular system,0.0
persons encountering health services in circumstances related to reproduction,0.05
"congenital anomaly of gallbladder, bile ducts, liver, pancreas",0.05
disorders of external ear,0.0
abdominal hernia,0.05
tinnitus,0.0
paroxysmal supraventricular tachycardia,0.0
hereditary hemochromatosis,0.05
acquired spondylolisthesis,0.05
family history,0.2
ovarian dysfunction,0.05
alopecia areata,0.05
"potential health hazards related to communicable diseases
potential health hazards related to communicable diseases",0.0
other acquired musculoskeletal deformity,0.05
nonspecific abnormal findings on radiological and other examination of biliary tract,0.05
sleep disorders,0.05
lipoma,0.05
bursitis,0.0
polycystic ovaries,0.0
macular puckering of retina,0.0
disorders of menstruation and other abnormal bleeding from female genital tract,0.05
inflammation of the eye,0.05
elevated blood pressure reading without diagnosis of hypertension,0.05
diseases of sebaceous glands,0.0
other abnormal glucose,0.1
peripheral enthesopathies and allied syndromes,0.1
"benign neoplasm of eye, uveal",0.0
hypothyroidism,0.05
benign neoplasm of eye,0.0
aspartate transaminase,0.1
alopecia,0.05
ovarian cyst,0.0
low density lipoprotein cholesterol,0.05
sebaceous cyst,0.0
"infertility, female",0.05
joint/ligament sprain,0.0
elevated prostate specific antigen [psa],0.05
irregular menstrual cycle,0.05
benign neoplasm of other endocrine glands and related structures,0.0
high density lipoprotein cholesterol,0.05
check fentanyl patch,0.05
phos nak packet,0.1
=lidocaine0.25%,0.0
bromfenac,0.1
barium sulfate,0.2
brilliantblueg0.25mg/mlophthinj,0.0
cpn2500ml,0.0
direct antiglobulin test - anti-complement component 3d,0.05
mycobacterium tuberculosis tuberculin stimulated gamma interferon/mitogen stimulated gamma interferon,0.05
bubble_gum_enema_500ml,0.1
displacement of intervertebral disc,0.0
metamyelocytes/100 leukocytes,0.05
"aftercare following surgery of the teeth, oral cavity and digestive system, nec",0.1
consult / referral to medical oncology,0.1
viable cells/100 cells,0.05
intestinal bypass or anastomosis status,0.2
=ertapenem,0.0
calcofluor smear,0.05
hypertrophy of breast (gynecomastia),0.0
family history of malignant neoplasm of gastrointestinal tract,0.1
consult / referral to radiation oncology,0.1
osmotic fragility,0.1
=dexamethasone,0.25
heterophile ab,0.05
hemoglobin a1/hemoglobin.total,0.1
hemoglobin s/hemoglobin.total,0.1
Hemoglobin.other/Hemoglobin.total,0.1
hemoglobin a2/hemoglobin.total,0.05
hemoglobin f/hemoglobin.total,0.1
hemoglobin c/hemoglobin.total,0.1
Hemoglobin E/Hemoglobin.total,0.1
hydrocele,0.0
disorders of bilirubin excretion,0.1
cytomegalovirus ab,0.1
hepatitis b adult vaccine,0.0
pathologist interpretation,0.2
protein s,0.05
protein s actual/normal,0.05
personal history of diseases of blood and blood-forming organs,0.1
calculus of bile duct,0.0
peritoneal adhesions (postoperative) (postinfection),0.1
other disorders of male genital organs,0.0
disorders of esophageal motility,0.1
myeloproliferative disease,0.05
hypercoagulable state,0.2
heart transplant/surgery,0.0
cellulitis and abscess of arm/hand,0.0
cancer of kidney and renal pelvis,0.0
"chronic kidney disease, stage i or ii",0.05
open-angle glaucoma,0.0
malignant neoplasm of ovary and other uterine adnexa,0.0
noninflammatory female genital disorders,0.0
cellulitis and abscess of trunk,0.05
malignant neoplasm of uterus,0.0
jaundice (not of newborn),0.1
senile cataract,0.0
inguinal hernia,0.05
raynaud's syndrome,0.05
acute bronchitis and bronchiolitis,0.0
nonrheumatic mitral valve disorders,0.0
secondary malignant neoplasm,0.0
secondary diabetes mellitus,0.05
pancreatic cancer,0.0
superficial cellulitis and abscess,0.05
posttraumatic stress disorder,0.0
sinoatrial node dysfunction (bradycardia),0.0
"polycythemia vera, secondary",0.05
other mental disorder,0.05
genetic test,0.1
rbc,0.05
red top hold,0.0
edta hold,0.0
prochlorperazine 5 mg oral tablet,0.2
cefpodoxime 100 mg oral tablet,0.1
calcium oxalate crystals,0.1
gray top hold (plasma),0.0
fluzone 2013-2014 formula,0.0
"bilirubin, total",0.1
glucagen,0.01
omeprazole 20 mg delayed release oral capsule,0.2
pantoprazole 40 mg injection,0.2
tab-a-vite with beta carotene tablet,0.05
hyaline casts,0.1
paroxysmal ventricular tachycardia,0.0
"other diagnostic procedures (interview, evaluation, consultation)",0.2
bicarbonate,0.05
chloride,0.05
adult failure to thrive,0.3
"creatinine, urine",0.1
problem specimen,0.1
amorphous crystals,0.05
cervicogenic headache - cervical region,0.0
prot regain s8 > m12,0.0
other diagnostic ultrasound,0.1
contrast medium injection supplement for intervertebral discography,0.0
"imaging for interventional radiology or interventional cardiology procedure level 10, performed in an imaging room",0.05
"imaging for interventional radiology or interventional cardiology procedure level 6, performed in an imaging room",0.05
"supplement for intraoperative harvesting of saphenous vein autograft for femoropopliteal bypass, femorotibial bypass, or femoroperoneal bypass",0.0
histopathological examination of biopsy of 4 anatomical structures,0.3
supplement for intravascular injection of radiological contrast agent during lower limb bypass surgery,0.0
supplement for use of a pulsed dye laser for destruction of flat angioma on 500 cm² to 700 cm²,0.0
supplement for use of a pulsed dye laser for destruction of flat angioma on 200 cm² to 350 cm²,0.0
supplement for use of a pulsed dye laser for destruction of flat angioma on 30 cm² to 60 cm²,0.0
supplement for use of a pulsed dye laser for destruction of flat angioma on 350 cm² to 500 cm²,0.0
supplement for use of a pulsed dye laser for destruction of flat angioma on less than 30 cm²,0.0
contrast agent supplement for radiographic arthrography injection,0.0
ancillary services,0.1
home health services,0.1
supply,0.0
calcium carbonate / cholecalciferol / magnesium oxide,0.05
calcium carbonate / cholecalciferol / vitamin k,0.05
calcium carbonate/vitamin d,0.05
calcium carbonate / cholecalciferol,0.0
calcium citrate/vitamin d,0.05
calcium citrate / cholecalciferol,0.05
anatomopathological examination of excision specimen from 3 anatomical structures,0.25
"right colectomy without restoration of continuity, by laparoscopy",0.65
"laparoscopic rectosigmoid resection extending beyond the douglas pouch, without restoration of continuity",0.85
gatifloxacin,0.1
mycophenolate,0.25
tinidazole,0.1
"bismuth/metronidazole/tetracycline - pylera 140 mg/125 mg/125 mg, capsule",0.1
postphlebitic syndrome,0.05
nodular lymphoma,0.05
chondrocalcinosis,0.05
cystic mastopathy,0.01
diaphragmatic paralysis,0.01
cervical conization,0.0
diabetic retinopathy,0.0
genital prolapse,0.05
chronic osteomyelitis,0.0
upper gi endoscopy,0.65
congenital myopathy,0.0
renal dysplasia,0.05
parkinson's disease,0.0
neurofibromatosis,0.0
ankylosis of joint,0.05
litholink kidney stone study,0.0
acute rheumatic heart disease,0.0
tubal ligation status,0.0
diabetic arthropathy,0.0
creatinine urine test 7,0.1
macular neuropathy,0.0
gouty arthropathy,0.05
arthropathy associated with infections,0.1
tomaculous neuropathy,0.05
senile dementia,0.0
urinary cotinine,0.05
panniculitis,0.1
postlaminectomy syndrome,0.0
apraclonidine,0.0
schwannomatosis,0.0
creatinine urine test 6,0.05
cervical biopsy,0.05
neurofibromatosis 2,0.0
polyneuropathy in diabetes,0.0
small bowel enteroscopy,0.25
nasal septum collection evacuation,0.0
sideroblastic anemia,0.05
creatinine urine test 5,0.1
fecal bilirubin,0.1
encephalopathy interpretation,0.05
urinary albumin percentage,0.05
side-viewing duodenoscopy,0.1
ovomucoid ige,0.05
chalazion excision,0.0
type 1 diabetes with renal manifestations,0.0
creatinine urine test 4,0.1
alzheimer's disease,0.0
creatinine poct,0.05
neurofibromatosis 1,0.0
other disorders of gallbladder,0.05
creatinine urine test 2,0.1
pneumoconiosis,0.0
gouty nephropathy,0.05
acute osteomyelitis,0.0
type 2 diabetes with renal manifestations,0.05
creatinine urine test 3,0.1
other congenital myopathy,0.0
collagen-adp,0.0
pneumovax 23,0.0
otitis media,0.0
septic shock,0.1
pneumococcal pneumonia,0.0
penicillamine,0.1
chronic periodontitis,0.0
return pressure,0.0
respiratory insufficiency,0.05
seminal fructose,0.0
subcutaneous morphine,0.1
isopropyl alcohol,0.0
pressure control ventilation,0.0
adriamycin,0.1
pulmonary embolism,0.0
dial phosphorus,0.0
seminal zinc,0.0
cocaine quantitative,0.0
bird interpretation,0.0
morbid obesity,0.1
threatened premature labor,0.0
urban density,0.0
urea vein,0.0
pneumococcal vaccine,0.0
oral gastric,0.1
associated treatment,0.75
hearing loss,0.0
acute periodontitis,0.0
pyogenic granuloma,0.05
streptomycin,0.0
urea dialysis,0.0
finger reimplantation,0.0
sodium ascorbate,0.05
aspartame,0.0
morphine concentration,0.05
salmon calcitonin,0.05
kidney donor,0.0
perioperative morphine,0.05
kidney transplant,0.0
superficial keratitis,0.01
insulin pump,0.0
amphetamine quantitative,0.0
chronic pain,0.25
dialysis catheter,0.05
fluorescein sodium,0.05
ice contact,0.0
methamphetamine quantitative,0.0
spontaneous aggregation,0.0
flow sensitivity,0.0
schedule induction,0.0
radiation exposure,0.05
assist device,0.05
late effect,0.25
cast application,0.0
diclofenac topical,0.1
fatty casts,0.1
ammonia t3,0.0
beef meat,0.0
lymphadenitis,0.1
ventilation rate,0.05
o2 inspired,0.0
rabies vaccine,0.0
inhibition interpretation,0.0
aluminum acetate,0.1
endometrial hyperplasia,0.05
dog bite,0.0
intraoperative jejunal and/or ileal enteroscopy,0.2
exploratory enterotomy via laparotomy,0.25
"therapeutic duodenotomy or partial duodenectomy, by laparotomy",0.1
exploratory duodenotomy via laparotomy,0.1
"extended small bowel enterolysis for acute obstruction, by laparotomy",0.1
therapeutic enterotomy via laparotomy,0.25
enterotoxigenic escherichia coli,0.1
enteric pathogens pcr,0.25
intestinal cutaneous stoma widening plasties,0.25
"organ or tissue replaced by transplant, intestines",0.75
cutaneous enterostomy by laparotomy,0.25
"suturing of wound or perforation of small intestine, by laparotomy",0.2
duodenal exclusion by laparotomy,0.1
bypass enterostomy by laparotomy,0.25
"diversion of duodenal and biliopancreatic secretions by reconstruction of the assembly after gastrectomy [duodenal diversion], by laparotomy",0.1
"duodenoduodenal anastomosis for congenital atresia or stenosis of the duodenum, by laparotomy",0.0
total colectomy with end ileostomy through laparotomy,0.85
nasal polyps,0.0
acute upper respiratory infections of multiple or unspecified sites,0.0
naloxegol,0.05
naldemedine,0.1
aclidinium,0.0
chlorpheniramine,0.05
medication,0.1
seborrheic dermatitis,0.0
mirapex,0.0
container,0.0
dermatomyositis,0.05
device,0.0
message,0.0
mandiff,0.0
ctdt,0.0
sugammadex,0.0
nephrotic syndrome without mention of glomerulonephritis,0.0
=sugammadex,0.0
propass,0.0
method,0.0
tiotropium,0.0
polymorphonuclear cells/monocytes,0.2
prot emoption j0-m6,0.0
monoclonal spike 2,0.05
"tofacitinib - xeljanz, 5 mg tablet",0.85
multiple myeloma panel,0.0
amyloid a serpl-mcnc,0.05
fluid monocyte percentage,0.1
monocyte,0.05
Cells.myeloperoxidase/100 cells,0.1
Cells.cytoplasmic CD79a/100 cells,0.05
daily vite tab,0.05
mitochondrial antibodies,0.1
polyneuropathy due to drugs,0.05
Cells.CD3/100 lymphocytes,0.1
Cells.cytoplasmic CD22/100 cells,0.05
monoclonal band,0.1
"patisiran 10 mg/5 ml, sol to be diluted for infusion, vial",0.0
brentuximab vedotin,0.1
mtx methotrexate,0.85
ramucirumab,0.1
tnf alpha inhibitor,0.85
"curad comfor .75x3"" mis medl",0.0
inflammatory protein,0.2
gemtuzumab ozogamicin,0.0
prot abira m1-3-12,0.0
aurothioglucose,0.1
blinatumomab,0.0
miscellaneous immunology,0.1
cyclosporin,0.85
tumor necrosis factor alpha,0.25
problem solution,0.0
monoclonal protein,0.1
interleukin il1,0.2
patiromer,0.1
nctransport immuno,0.0
carcinological purpose histopathological examination of segmental small intestine resection specimen,0.25
adacel,0.0
typhoid vaccine,0.0
enteroaggregative escherichia coli polymerase chain reaction,0.1
carcinological histopathological examination of total colectomy specimen,0.85
enteric histolytica pcr,0.1
"secondary restoration of digestive continuity after colectomy, by laparotomy",0.85
carcinological histopathological examination of endoscopic small bowel resection specimen,0.25
carcinological anatomopathological examination of anal canal and/or anal margin excision specimen,0.25
"total colectomy with ileoanal anastomosis, by laparotomy",1.0
cholecalciferol / vitamin k2,0.05
"occult blood, diagnostic, stool",0.65
hematemesis,0.25
cisapride,0.1
tst/ppd,0.0
"adalimumab - amgevita, 20 mg/0.4 ml injection",0.85
"adalimumab - humira, 80 mg/0.8 ml inj pen",0.85
m103,0.0
bayer contor tes next,0.0
filter_1.2_micron_-_chartwell,0.0
cryoglobulin,0.1
"forlaxlib adult 10 g, powder for oral solution, sachet",0.1
hbiom receptor,0.0
eus-fna biopsy,0.25
beta 1 sg,0.0
8 cooh (uro) ur,0.0
problems in relationship with spouse or partner,0.0
tissue immunofluorescence assay observation cerebrospinal fluid,0.05
immunoglobulin a,0.1
neural tube defect risk,0.0
complement factor b,0.05
csf sympathetic protein 0-7,0.0
"total cystectomy with orthotopic neobladder replacement enterocystoplasty using a detubularized loop, via laparotomy",0.1
dyazide,0.0
o2pt,0.0
ethyl glucuronide,0.0
Parainfluenza virus RNA,0.05
foreign body or penetrating object in the skin - industrial premises and construction site,0.0
reticulocyte hemoglobin content,0.1
@bd insulin syr 0.5ml 31gx5/,0.0
silver birch (betula verrucosa) ige,0.0
"encounter for supervision of normal pregnancy, unspecified, second trimester",0.0
=plasma-lytea,0.0
oat flour,0.0
"arterial pco2 calculated, relocated",0.0
"gauze,iodoform",0.01
serial number,0.0
west nile virus rna,0.0
legionella antigen det dfa,0.05
calcium on t1,0.05
Eastern equine encephalitis virus IgG and IgM,0.0
"mechanical complication of unspecified genitourinary device, implant, and graft",0.0
inspiratory ratio,0.05
triglyceride,0.05
ceftriaxone 1000 mg injection,0.1
"traumatic injury of the ureter, without penetrating abdominal wound",0.0
ct #4 fluctuate,0.0
homogenous nuclear ab pattern,0.05
mesothelial cells/100 leukocytes,0.1
24 hr nifedipine 60 mg extended release oral tablet,0.05
red cell phenotype,0.05
levothyroxine,0.0
borrelia burgdorferi 58kd igg,0.05
cd25+,0.1
teduglutide,0.1
Methylenedioxyethylamphetamine,0.0
cleansing cloth,0.0
blast cells percentage,0.05
lorazepam,0.01
ra one daily essential tablet,0.0
family analysis,0.0
Toxoplasma gondii IgA,0.05
Anisakis IgE,0.05
"beclometasone/formoterol/glycopyrronium - trimbow, 87 mcg/5 mcg/9 mcg/dose, inhalation solution",0.05
urea ur-scnc,0.05
granularcom2qual,0.0
treponema pallidum igg,0.01
sialolithiasis,0.0
aquaporin 4 water channel igg,0.05
hemoglobin f,0.05
broad casts,0.0
rigid laryngo-tracheo-bronchoscopy,0.0
g/d tcr,0.0
number of gp1b sites pat,0.0
intracranial lesion biopsy by craniotomy,0.0
fixed income fund,0.0
point of care leukocyte count,0.1
potassium_phosphate_30_mmol/ns_250ml_premix,0.05
Homovanillate/Creatinine,0.1
urine leukocyte esterase,0.05
thyroid stimulating immunoglobulins,0.0
2-Oxoisocaproate/Creatinine,0.0
"pneumococcal vaccine - pneumo 23, inj sol (prefilled syringe)",0.0
milk,0.0
measure 2 to date,0.0
carbon tempering,0.0
beta-2 globulin fraction concentration,0.1
glucose fasting,0.05
"self-poisoning by other biological substances, nec - school and public area",0.0
"change of a pancreatic duct endoprosthesis, by esophagogastroduodenoscopy",0.05
subarachnoid hemorrhage,0.0
"partial resection of the tibia and/or fibula without interruption of continuity, through multiple approaches",0.0
mild alcohol intoxication,0.0
Bordetella parapertussis DNA,0.0
slan-positive non-classical monocytes,0.05
fatty acid,0.1
one touch ultra mini kit (pink),0.0
sample nature 2,0.0
radioisotope pulmonary scan,0.05
prot prom8785 spacin,0.0
ige allergen cod fish,0.0
alternaria alternata igg,0.05
resection of the prominent dome of hepatic hydatid cyst by laparotomy,0.0
non invasive blood pressure mean,0.0
immunoglobulin a heavy-light chain kappa,0.1
early or threatened labor; hemorrhage in early pregnancy,0.0
samarium,0.0
=vitamink,0.0
corticotropin,0.2
homocystine,0.05
Complement factor I,0.05
clot retraction,0.0
t1 duration,0.0
phosphorus over time 1,0.05
allergy weed pollen panel,0.0
trap 25 µm,0.0
hdl (high density lipoprotein) cholesterol,0.0
icu panel,0.05
capillary ph-sg,0.0
muscle and tyrosine antibody immunofluorescence assay cerebrospinal fluid,0.05
"carcinological anatomopathological examination of tumor resection specimen from the greater omentum, peritoneum, and/or peritoneal fold [meso]",0.1
la crosse virus igg and igm,0.0
"human normal immunoglobulins 8 g (gammanorm), inj sol, vial 48 ml",0.1
Coagulation factor IX Ag,0.05
number of mutations,0.0
"fall on the same level due to ice and snow, school, public place",0.0
urinalysis glucose,0.05
prot bioams incl lcr,0.1
goosefoot (chenopodium album) ige,0.05
ac a-m2/bcoadc-e2,0.0
"external drainage of multiple bile ducts with stent placement, via percutaneous approach with ultrasound and/or radiologic guidance",0.0
castor oil / peruvian balsam / trypsin,0.05
orthopedic reduction of fracture and/or dislocation of the forefoot,0.0
travoprost,0.0
somatostatin,0.1
goose flesh,0.0
matutes score,0.1
oxycodone concentration test,0.05
testosterone free,0.0
il28b gene associated variant rs12979860,0.1
"lenalidomide, 20 mg capsule",0.0
expiratory ratio,0.0
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 2 cell-based assay immunofluores,0.0
tricyclic antidepressant,0.05
number of granular casts per low power field,0.05
"bursitis, unspecified - leg",0.0
impaired skin odor #10,0.1
blade no.,0.0
"excision of pedunculated uterine lesion delivered through the cervix, via vaginal route",0.0
=sodiumbicarb4.2%,0.0
other artificial opening status,0.2
amobarbital,0.0
"etilefrine 10 mg/1 ml serb, injectable solution, ampoule",0.0
"amlodipine+valsartan 10 mg+160 mg (accord lab), tablet",0.0
3-methylhistidine,0.05
dipstick urine blood test,0.05
anti-jo1 antibodies,0.1
tbo-filgrastim,0.1
basis,0.0
Microscopic exam,0.25
poct sars-cov-2 antigen via card,0.0
vrs,0.0
cd3+,0.0
acetaminophen 500 mg oral tablet,0.0
upper limb artery resection-anastomosis by direct approach,0.0
pregnant,0.05
threonine/creatinine,0.05
epidural medication,0.05
corneal degenerations,0.0
valproate_sodium_750_mg/15_ml_syrup,0.0
urinary albumin,0.05
endogenous terminal value conclusion,0.0
other kidney and urinary tract diagnoses with cc,0.05
"acebutolol, 200 mg tab, scored",0.0
"pantoprazole 20 mg (inipomp), gastro-resistant tablet aip mwi pl",0.25
calciumchloride13.6meq/10mldialysis/tpn,0.0
rubella virus vaccine live (wistar ra 27-3 strain),0.0
oxytocin 0.02unt/ml/dextrose 5% inj,0.0
glucose mg/dl,0.0
erythroblast count per 100 white blood cells,0.05
indicated treatment,0.0
festuca elatior ab.ige.rast class,0.0
evacuation of a thyroid lodge collection by cervicotomy,0.0
congenital anomalies of great vessels,0.0
fall from a chair - school and public place,0.0
scar revision after urethroplasty,0.0
megasphaera sp dna,0.05
iga equal to,0.0
autopsy fungus culture,0.0
time 8,0.0
esophageal cutaneous fistula closure by cervicotomy,0.05
antithrombin iii,0.05
"motor vehicle traffic accident due to loss of control, without collision on the highway, injuring driver of motor vehicle other than motorcycle",0.0
factor viii chromogenic,0.0
equipment,0.0
other antibiotic,0.2
"aspiration of fluid as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure",0.1
"fall, being carried or supported by others - home",0.0
restraint device (violent),0.0
ursodiol,0.1
"mri of 3 or more segments of the spine and its contents, without intravenous contrast injection",0.05
sanger sequencing for point mutation detection,0.1
consult / referral to comprehensive breast center,0.0
serine protease,0.05
packed erythrocytes units available,0.05
Calcium.ionized/Calcium.total,0.05
giardia lamblia ab,0.1
anti m2 mitochondrial ab - igg,0.1
triamterene,0.1
aspirin / oxycodone hydrochloride / oxycodone terephthalate,0.05
lymphocytic choriomeningitis virus igg,0.0
non-traumatic intracerebral hematoma evacuation by craniotomy,0.0
anti-nf 186 antibodies,0.2
bictegravir / emtricitabine / tenofovir alafenamide,0.0
"buprenorphine screen, urine",0.05
flecainide,0.0
"closure of spina bifida with myelomeningocele, via posterior approach",0.0
baclofen 10 mg oral tablet,0.0
"surfactant deficiency, congenital protein",0.0
liquid amylase,0.05
urinary creatinine and magnesium per deciliter,0.05
predicted glomerular filtration rate,0.05
serum chloride concentration,0.1
threonine,0.0
"bilateral total arthrectomy and/or posterior osteotomy for rigid spinal deformity with arthrodesis and instrumental correction, on 10 or more vertebrae, via posterior approach",0.0
complementary conclusion,0.0
microscopic observation,0.2
"macrogol (generic forlax 4 g), sachet (pediatric use only)",0.25
self-inflicted injury by unspecified means - home,0.0
250 ml glucose 100 mg/ml injection,0.0
total carnitine,0.05
consult / referral to vascular surgery,0.05
mature basophils percentage,0.05
laparoscopic posterior hysteropexy [promontofixation],0.0
"destruction of several foci and/or interruption of several ventricular arrhythmogenic circuits with radiofrequency current, by transcutaneous vascular route",0.0
Latex recombinant (rHev b) 5 IgE,0.0
haemophilus influenzae b igg,0.0
other laboratory controls,0.05
"catheter,external",0.05
mutated gck gene,0.05
"pedal cycle driver injured in noncollision transport accident in traffic accident, subsequent encounter",0.0
bee rapid api 214 square meters,0.0
arctic sun/alsius set temp,0.0
"recanalization of an upper limb artery with placement of a covered stent, via transcutaneous arterial route",0.0
14 g phlebitis scale,0.0
acetazolamide 250 mg oral tablet,0.05
gpiiia (y2/51),0.0
"insulin humulin nph, cart",0.0
jc virus dna,0.1
urea dial 3,0.0
pnn flaer-/cd24- (types 2 and 3),0.0
mid-cell percentage - predicted,0.0
serum collected on,0.0
cd2 cells nfr bld,0.1
blood product unit id,0.0
HIV 2 gp36 Ab,0.0
dry pellet packaging,0.0
aspartate,0.0
hemoglobin a1c test - differential cell count type,0.05
dexcom g6    mis tra,0.0
"coronary revascularization with 2 arterial grafts and 2 distal anastomoses, through thoracotomy with cpb",0.0
"other urethral stricture, male, unspecified site",0.0
normoblasts nfr mar manual,0.0
"calcium heparin (generic calciparine), 5,000 iu/0.2 ml injection",0.0
g6pd/pk ratio,0.05
"t(9;22)(q34.1;q11)(abl1,bcr) b2a2+b3a2 fusion transcript/control transcript (international scale)",0.0
sodium ur tp,0.0
factor xii 1/10,0.0
screening for other and unspecified deficiency anemia,0.2
knee disarticulation,0.0
carboxy tetrahydrocannabinol,0.1
pbiom receptor,0.0
one touch suresoft lancing dev/gent,0.0
ana test result,0.1
"replacement of the ascending thoracic aorta and the horizontal aorta without replacement of the aortic valve, with reimplantation of the coronary arteries, by thoracotomy with cpb",0.0
"resection of a cervical rib, via supraclavicular approach",0.0
pathology findings,0.75
"hand or wrist procedures, except major thumb or joint procedures with cc/mcc",0.0
biperiden,0.0
influenza virus a ag,0.0
human papilloma virus 16 dna,0.0
streptococcus pneumoniae dna,0.0
parenteral nut: numetah g16% (e) 517 kcal/500 ml (cvc or dilute piv),0.1
ropivacaine0.2%/ns10mlsyringe,0.0
influenza a virus a/california/7/2009 (h1n1) antigen / influenza a virus a/hong kong/4801/2014 (h3n2) antigen / influenza b virus b/brisbane/60/2008 antigen / influenza b virus b/phuket/3073/2013 antigen,0.0
surface,0.0
other specified transport accidents,0.0
"escitalopram, 10 mg tablet, scored",0.05
laparoscopic unisegmentectomy of the liver,0.0
accident caused by excessive heat due to weather conditions,0.0
taurine,0.0
"drainage of an extensive digital or digitocarpal synovial sheath abscess in the hand and/or forearm, by direct approach",0.0
promyelocytes/100 leukocytes,0.0
at3-thrombin activity,0.0
round cells,0.05
kit allelic burden quantification by digital pcr,0.05
"aortic valve replacement with prosthesis in non-anatomical position, by thoracotomy with cpb",0.0
"fluorescein angiography of the posterior segment of the eye, with transcutaneous intravenous injection and image overlay",0.0
=clevidipine,0.0
blood glucose test,0.05
argatroban,0.0
igg on b cells (cmf),0.1
position,0.0
nil,0.0
osteoporosis in endocrine disorders (e00-e34) - main,0.05
white gold / yellow gold,0.0
encounter for removal of intrauterine contraceptive device,0.0
aspirin / oxycodone,0.05
"patch,eye",0.0
"release of the circumflex nerve, by direct approach",0.0
"intraluminal dilation of the common iliac artery and/or external iliac artery without stent placement, by transcutaneous arterial route",0.0
aprepitant,0.1
granular casts in urine test - iris method,0.05
cancer ag 15-3,0.0
"thoracic vessel and/or heart ct scan, with abdominal and/or pelvis vessel ct scan [thoracic angiography with abdominal and/or pelvic angiography]",0.1
vaccination not carried out because of caregiver refusal,0.0
transplant heart fragments of fibrous tissue,0.0
shivering,0.05
"intraventricular or intracystic cerebral administration session of anticancer pharmacological agent, by an implanted device",0.0
cefdinir,0.0
basophilic polychromatophilia %,0.05
"poisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter",0.0
open reduction and internal fixation of fronto-naso-maxillary fracture via facial approach,0.0
presence of right artificial knee joint,0.0
glyburide 5 mg oral tablet,0.0
unilateral total nephrectomy by laparotomy,0.0
esmolol,0.0
blades and blocks,0.0
reticulocyte percentage,0.1
esophageal dilation with radiologic guidance,0.1
mastectomy procedures,0.0
ct #2 fluctuate,0.0
vanadium,0.0
cd16+ cd45ra+ nvd2,0.0
gene studied identifier,0.0
prostate-specific antigen,0.0
abnormal arterial blood gases,0.1
value added tax (vat),0.0
human leukocyte antigen crossmatch report,0.05
"tendon section or lengthening for correction of vicious attitude of the hip, through several approaches",0.0
diltiazem hydrochloride 5 mg/ml injection,0.0
quantadeno/pcr,0.05
amorphous crystals count,0.0
nortriptyline,0.0
coxsackievirus a10 ab,0.05
"encorafenib - braftovi, 75 mg capsule",0.05
il28b gene mutation,0.1
factor v,0.05
interpretationabacav,0.0
"therapeutic compression with inhalation of oxygen-enriched mixture or pure oxygen at an initial pressure equal to or greater than 280 kilopascals [kpa], lasting 1 to 3 hours",0.0
total platelet binding receptor b reporting limit,0.0
segmented neutrophils percentage,0.1
total triiodothyronine,0.0
benzodiazepine dosage 2,0.0
screening for depression,0.05
factor viiic thrombosis,0.05
intraoperative electrocorticographic monitoring of spontaneous and/or evoked brain activity,0.0
plasma cells,0.1
"ezetimibe, 10 mg tablet",0.1
Ethylmalonate/Creatinine,0.05
transcatheter arterial injection of pharmacologic agent into a branch of the coronary artery for reduction of interventricular septal thickness,0.0
Zinc/Creatinine,0.05
prot mmy3019 c9-eot,0.0
plasminogen,0.05
risperidone,0.05
Activated clotting time.kaolin induced,0.05
sod_hyaluronate_10mg/ml_syr_0.4ml,0.1
"restoration of a tooth in the incisor-canine sector on 1 angle with material inserted in plastic phase, without radicular anchorage",0.0
mody 5 hnf1b or tcf2,0.05
"somatropin 5 mg (norditropin flexpro), inj sol, pen 1.5 ml",0.0
removal of an external fixator or an external system for progressive limb lengthening,0.0
open reduction and internal fixation of a simple bimalleolar fracture,0.0
cd66c+,0.0
partial epiglottectomy by direct laryngoscopy with laser,0.0
oncology biobank,0.0
single pregnancy care,0.0
time 9,0.0
pain management,0.25
glycoprotein iib (cd41),0.0
dysmorphic rbc/100 rbc nfr urns micro,0.1
"nutrineal pd4 dpca, double bag luer 2l (ref dpb 9656)",0.1
nadolol 10mg capsule,0.0
"treadmill or ergometer bicycle exercise test, with blood gas measurement [simplified exercise test] [exercise blood gas analysis]",0.05
prot softrih s16/s20,0.0
cnranip paris(1rana),0.0
Fasciola hepatica Ab,0.05
monoclonal beta spike,0.05
"reinsertion and/or suturing of several tendons of the rotator cuff of the shoulder, by direct approach",0.0
id after sequencing,0.0
lcr origin,0.0
ct #2 leak,0.1
cytopathological examination of the smear of 2 differentiated samples from anatomical structure puncture product,0.1
emicizumab dosing,0.05
open reduction and internal fixation of extra-articular fractures of several bones of the hand,0.0
biliopancreatic echoendoscopy without biopsy,0.1
indwelling (portacath) port #1,0.05
1 left arm measure,0.0
"esomeprazole 40 mg (almus lab), gastro-resistant capsule",0.2
"resection of a tumor of the inner third of the middle level of the skull base involving the sphenoorbital angle, by craniotomy",0.0
uropor 24h sfr ur,0.0
correction of labionasal sequelae of a bilateral cleft lip and palate,0.0
"neo-codion, tablets",0.05
calculated cs dna volume (cf10/vf50),0.0
csf igg/albumin ratio,0.05
biological fluid,0.1
transcutaneous vascular cervicocephalic arteriography for the diagnosis of brain death,0.0
Cells.CD24-FLAER-/100 cells.CD15,0.0
scleritis and episcleritis in diseases classified elsewhere,0.1
r.pcr.c.pneumoresp,0.0
urine drug of abuse screen,0.0
creatinine urine,0.1
sexually transmitted infections (not hiv or hepatitis),0.0
hm vit d3 50mcg 2000 u sftgl,0.05
pca total with boluses (hydromorphone),0.1
kitchen of unspecified non-institutional (private) residence as the place of occurrence of the external cause,0.0
hepatitis e virus igg,0.05
"supraselective in situ fibrinolysis of intracranial artery, by transcutaneous arterial route",0.0
activated clotting time - operating room (point of care),0.05
"poc pco2, capillary",0.1
ascites proteins,0.1
pregnancy induced hypertension panel,0.0
comprehensive liquid chromatography-mass spectrometry,0.1
urine pregnancy test by clinitek,0.0
foreign body injury,0.05
estradiol free,0.0
closed reduction and internal fixation of a proximal forearm bone fracture,0.0
fracture of vertebral column without mention of spinal cord injury,0.0
"creatinine, whole blood",0.1
self-poisoning by alcohol and exposure to alcohol - street or highway,0.0
other respiratory system diagnoses without mcc,0.0
phosphorus,0.05
hosp. prep: 10% salicylated vaseline,0.1
barbiturates test,0.0
fall from playground equipment - unspecified location,0.0
latex ige,0.05
selenious acid,0.0
16 g phlebitis scale,0.0
cd3+ cells,0.1
cmf 3rd tube,0.0
anti-cv2 d research,0.05
ratio viiic/rag,0.0
free kappa,0.05
"total protein, pleural",0.05
endoscopic resection of urethral tumor,0.0
known or suspected fetal abnormality affecting management of mother,0.0
morphology analysis in complete blood count,0.1
penicillium notatum ab.ige.rast class,0.0
lct o/n,0.0
"extended small bowel enterolysis for acute obstruction, by laparoscopy",0.1
pradaxa dosage,0.0
acanth (qvarnstrom),0.0
"excision of 2 to 5 subcutaneous lesions above the fascia, less than 3 cm in greatest dimension",0.0
Grapefruit (Citrus paradisis) IgE,0.05
pulse oximetry,0.05
fabrication of a static orthosis for 3 or more fingers,0.0
"drug test, general toxicology, blood",0.05
low-density lipoprotein cholesterol calculated,0.05
adverse effect: phenothiazine antipsychotics and neuroleptics,0.1
"on zinc, frozen",0.0
cd3 positive cell percentage,0.1
fish box,0.0
"underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter",0.0
"bordetella pertussis filamentous hemagglutinin vaccine, inactivated / bordetella pertussis toxoid vaccine, inactivated / diphtheria toxoid vaccine, inactivated / tetanus toxoid vaccine, inactivated",0.0
activities involving personal bathing and showering,0.0
encounter for nonprocreative genetic counseling,0.0
mycobacterium tuberculosis complex dna,0.05
tryptophan/creat ur-srto,0.05
Beta lactoglobulin IgE,0.05
cmv pcr/bal,0.05
bd safetgld ins 0.3 ml 8mmx31g,0.0
risk,0.1
parenteral nut: smofkabiven (e) 550kcal/493ml (tpn),0.2
r.pcr.u.urealybiop,0.1
"40 winks, 50 mg oral tablet",0.0
smpr b,0.0
respiratory disorders in other diffuse diseases of connective tissue,0.05
granulocytes.immature/100 leukocytes,0.1
ebv pcr/csf,0.05
pre-inc dop-ams prot,0.0
"outcome of delivery, single liveborn",0.0
clopidogrel,0.05
"intraluminal dilation of the superior vena cava without stent placement, by percutaneous venous approach",0.0
"car driver injured in collision with heavy transport vehicle or bus in traffic accident, initial encounter",0.0
counseling on substance use and abuse,0.05
total formula,0.0
"compression, crushing, jamming with objects - unspecified place",0.0
Collection start time,0.0
osteoporosis in multiple myeloma (c900) - forearm,0.0
epoprostenol,0.1
trifluoperazine,0.1
gestational age,0.0
neutrophil cytoplasmic ab.classic,0.1
mycoph. t12 {c,0.0
vonwillebrand/ahf_factor_cmplx_100u,0.0
ref. see external documents,0.0
